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GENERAL INTRODUCTION 
Since the discovery of dopamine as a normal constituent of the manma-
lian brain (Montagu, 1957; Weil-Malherbe et al., 1957) a vast number 
of studies have been performed with respect to this monoamine. Marked 
differences in the regional distribution of dopamine and noradrenaline 
in the brain (Bertler et al., 1959; Carlseon, 1959) led to the idea that 
dopamine, apart from its role as inmediate precursor of noradrenaline, 
might have physiological functions of its own. The introduction of a 
sensitive fluorescence histochemical technique (Falck, 1962; Falck et 
al., 1962) for direct visualization of monoamines, and subsequent modi-
fications of this technique, resulted in a detailed mapping of catechol-
aminergic and serotonergic pathways in the brain (Fuxe, 1965; Andén et 
al., 1966; lingerstedt, 1971; Lindvall et al., 1974à). The most important 
dopamine neuron systems, at present known, are: 
- the nigro-neostriatal dopamine system, with cell bodies in the pars 
compacta of the substantia nigra (A 9-group according to Dahlström 
and Fuxe, 1965) and axons ascending to the neostriatum. 
- the mesolimbic dopamine system, with cell bodies dorsocranially to the 
interpeduncular nucleus (A 10-group) and axons ascending to structures 
in the limbic forebrain such as the nucleus accumbens, the tuberculum 
olfactorium and the dorsal part of the nucleus interstitialis striae 
terminalis. 
- the tubero-infundibular system, which originates in the arcuate nucleus 
of the hypothalamus and innervates the median eminence. 
More recently two other dopaminergic systems have been described, viz. 
- the mesocortical dopamine system, with cell bodies in the ventral 
tegmental area of the mesencephalon (probably A 9- and A 10-group) and 
axons ascending to several regions of the cerebral cortex (Thierry et 
al., 1973; Lindvall et al., 1974b; Fuxe et al., 1974a). 
- the incerto-hypothalamic dopamine system, originating in different 
cell groups in the diencephalon and innervating parts of the hypotha-
lamus, preoptic area and probably also of the septal area (Björklund 
et al., 1975). 
These dopamine pathways have been described for the rat brain. There is 
much evidence, however, that at least the 3 first mentioned neuron sys-
tems are present in the brains of other mammals too, including the human 
brain (Olson et al., 1973; Nobin et al., 1973), although minor differences 
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may exisc. 
Evidence in favour of an important role of dopamine in neurotrans-
mission processes has been reviewed by Homykiewicz (1966). Disturbances 
in dopaminergic transmission have been suggested in a variety of neuro-
logical and psychiatric disorders, notably Parkinson's disease and 
schizophrenia. 
In Parkinson's disease, a syndrome with hypokinesia, rigidity and 
tremor as most prominent clinical features, the most conspicuous neuro-
pathological findings are loss of neurones, gliosis and the presence of 
Lewy bodies (especially in the idiopathic form of the disease) in the 
substantia nigra and, to a lesser extent, also in some other pigmented 
structures such as the locus coeruleus. Degenerative changes in the 
lenticular nucleus are usually less severe in the idiopathic form. The 
finding of a strong reduction of the dopamine content of the corpus 
striatum in patients with Parkinson's disease (Ehringer et al., 1960), 
together with data from animal studies, resulted in the beneficial 
treatment of this disease with the dopamine precursor L-DOPA (Birkmayer 
et al., 1961; Cotzias et al., 1967). Very little is known about distur-
bances in dopaminergic systems other than the nigro-neostriatal one. In 
this respect it is worth mentioning that Fahn et al. (1971) found a 
strong reduction of the dopamine content inter alia in the inferior head 
of the caudate nucleus, including the nucleus accumbens, of Parkinsonian 
patients. Moreover, they found that this region in normal humans con-
tained a concentration of noradrenaline, which was high in comparison 
to other regions of the neostriatum. In Parkinsonian patients the nor-
adrenaline content of this region was also strongly reduced. Furthermore, 
one can speculate whether also the sometimes reported anosmia might in-
dicate an involvement of the mesolimbic dopamine system, especially of 
the tuberculum olfactorium. Although there is little doubt about the 
significance of dopamine at the moment, there is a lot of evidence to 
suggest that it is certainly not the only neurotransmitter, which is 
involved in this disease. Changes in the content of serotonin and nor-
adrenaline in the brains of Parkinsonian patients, as well as the 
therapeutic action of anti-acetylcholine drugs, indicate that other 
transmitter systems are also deficient or brought out of balance. 
Less firmly based is the role of dopamine in schizophrenia. This 
may partly be due to the fact that no clear neuropathological findings 
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in the brains of schizophrenic persons have been reported, like in 
Parkinson's disease. Moreover, the term schizophrenia may refer to a 
group of syndromes with some conmon features rather than to a definite 
nosological entity. According to the concept of Bleuler fundamental 
symptoms consist of disturbances in association, manifesting themselves 
as peculiar thought disorders, disturbances in affect, which is often 
flat and inappropriate and further of ambivalence and autism. Prominent 
accessory symptoms may include hallucinations, delusions or catatonic 
behaviour. 
A great number of hypotheses, based inter alia on genetic factors, 
family and social experiences or stresses, and biochemical abnormali-
ties have been postulated with respect to the etiology of schizophrenia. 
During the last decade much attention has been directed to the role of 
the brain neurotransmitters, especially dopamine, serotonin, noradrena-
line and more recently also GABA (Roberts, 1972; Frederiksen, 1975). 
Although there is evidence to support the hypothesis that an impaired 
balance between several transmitter systems underlies the symptomatology 
of schizophrenia (Cools, 1975), here the attention will be focussed upon 
the role of dopamine. 
Evidence in favour of such a role is provided by the study of drugs 
that can alleviate symptoms of schizophrenia, and drugs that can induce 
or exacerbate psychotic symptoms. Among the agents used in the treatment 
of schizophrenia, neuroleptic drugs (phenothiazines, thioxanthenes, 
butyrophenones) have generally been found to be highly efficacious. 
Although these drugs show a variety of actions, it seems that their 
interaction with brain dopamine correlates best with their antipsychotic 
effect (van Rossum, 1967; Matthyse, 1973; Snyder et al., 1974; Iversen, 
1975). So, neuroleptics have been found to enhance dopamine turnover, 
to inhibit the dopamine-induced activation of adenylate cyclase, and to 
antagonize several behavioural effects of dopamine and dopamine agonists. 
Moreover, a prominent side-effect of these drugs is the production of 
Parkinson-like extrapyramidal symptoms, although the incidence of such 
effects in some drugs, like clozapine and thioridazine, seems to be low. 
Whereas the extrapyramidal side-effects of neuroleptics are generally 
attributed to their action upon the nigro-neostriatal dopamine system, 
several authors (van Rossum et al., 1970; Stevens, 1973; Matthyse, 1973; 
Andén, 1972) have suggested that their antipsychotic action might be 
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related to the mesolinibic system, although direct evidence for this 
assumption is not yet abundant. Apart from a generally presumed ant-
aganietic action on postsynaptic dopamine receptors, actions on pre-
synaptic mechanisms should also be considered (Seeman et al., 1975). 
On the other hand, psychiatric side-effects, like confusion, hyper-
activity, agitation and sometimes hallucinations and delusions, have 
been observed by many investigators in Parkinsonian patients treated 
with the dopamine precursor L-DOPA. In schizophrenic patients a 
behavioural worsening and an increase in psychotic symptomatology has 
been reported in response to the administration of L-DOPA (Angrist et 
al., 1973). Furthermore, intoxication with amphetamine and amphetamine-
-like compounds can induce a psychotic behaviour, which is hardly dis-
tinguishable from paranoid schizophrenia (Connell, 1958) and in schizo-
phrenic patients amphetamine produces an exacerbation of the disease 
(Davis et al., 1973). The stereotyped compulsive behaviour, which is 
often seen following amphetamine abuse, is also highly characteristic 
for the effects of amphetamine and related drugs in experimental animals 
(Randrup et al., 1967; Ellinwood, 1971). A lot of evidence suggests that 
this stereotyped behaviour is mediated by dopaminergic mechanisms in the 
brain and that dopamine also plays an important role in the locomotor 
stimulant action of these drugs (van Rossum, 1970). 
Until now most of the research with respect to the brain dopamine 
has been concentrated upon the nigro-neostriatal system and only a few 
attempts have been made to investigate the role of other dopaminergic 
systems. Since drugs, which interfere with dopamine, like neuroleptics, 
L-DOPA and anchetamine, are widely used both inside and outside the 
clinic, a better understanding of the mechanisms of their therapeutic 
action and side-effects is wanted. In this respect it is necessary to 
know their influence upon other dopaminergic systems. The purpose of 
the present investigations, therefore, was to throw some light upon the 
role of another major ascending system, viz. the mesolimbic dopamine 
system. In view of the fact that the most detailed mapping of this system 
has been performed for the rat brain, the rat was used as an experimental 
animal. In order to study the effects of drugs upon the mesolimbic dopa-
mine system without concomitantly reaching other dopaminergic structures, 
the technique of stereotaxic injections was used. Since the nucleus ac-
cumbens is a major terminal area of the mesolimbic dopamine system, and 
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by virtue of its shape in the rat brain is better suited for the intra­
cerebral injection technique than the other terminal areas, the experi­
ments have been mainly concentrated upon this nucleus. 
In the rat the nucleus accumbens (also called nucleus accumbens 
septi) forms a rather conspicuous structure, situated beneath the lateral 
ventricle between the head of the caudate nucleus and the septal area. 
Dorsolaterally, there is no sharp delineation between the nucleus accum­
bens and the neostriatum and, in histological and histochemical respect, 
both structures appear virtually identical, the only difference being 
that the nucleus ассшЛепв is relatively free from traversing fibres. 
Also the ventral boundary of the nucleus accumbens with the deep layer 
of the tuberculum olfactorium is not sharply defined, in contrast to its 
medial boundary, where the septal nuclei are easily distinguishable. A 
more detailed anatomical description of the nucleus accumbens in the rat 
as well as a variety of other manuals, including man, is given by Koike-
gami et al. (1967). In view of the similarity between the nucleus accum­
bens and the caudate nucleus, many investigators have considered the 
nucleus accumbens as a ventromedial extension of the neostriatum. This 
opinion is strenghtened by the finding that both structures contain high 
ccncentrations of dopamine and acetylcholine (Koslow et al., 1974) and 
also GABA (Balcom et al., 1975). However, with regard to its fibre con­
nections the nucleus accumbens clearly differs from the caudate nucleus 
(Wilson, 1972). In contrast to the neostriatum the nucleus accumbens 
does not seem to receive afferent fibres from the neocortex, but receives 
fibres from various structures in the limbic system such as the hippo­
campus, the amygdala and septal nuclei. As already mentioned, there are 
also differences with respect to the dopaminergic input. The nucleus 
accumbens receives fibres from the A 10-group, whereas the caudate 
nucleus receives fibres from the A 9-group in the substantia nigra. 
According to Wilson (1972) the main efferent connection of the nucleus 
accunbens is to the substantia innominata, whereas the caudate nucleus 
projects mainly to the globus pallidus, the entopeduncular nucleus and 
the substantia nigra. It is likely that this difference in connections 
between the nucleus accumbens and the caudate nucleus will result in 
functional differences too between both structures. 
Few data, however, are available with respect to the functional 
aspects of the nucleus accumbens and the mesolimbic dopamine system. 
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Bilateral lestons of the nucleus accumbens have been reported to cause 
transient increase in food intake, elevated activity levels, increased 
sensitivity to shock and faster acquisition of conditioned avoidance 
responses, as well as a reduced telencephalic serotonin content (Lorens 
et al., 1970). Furthermore, the nucleus accumbens has been shown to be 
an important site for self-stimulation (Rolls, 1971; Broekkamp et al., 
1974). Self-stimulation can also be produced by placement of electrodes 
in the A 10-group and the adjacent region of the ventral mesencephalic 
tegmentum (Crow, 1972; Broekkamp et al., 1975). Crow found that stimula­
tion of this region resulted in a marked increase in locomotor activity 
and has proposed the view that the dopamine containing neurones in the 
midbrain might constitute an "incentive motivational" system (Crow, 
1973). 
The investigations described in this thesis are divided into 3 sections. 
Section I deals with the effects of injections of dopamine directly 
into the nucleus accumbens. Since it was found in preliminary experiments 
that the most striking alterations of behaviour following such injections 
consisted of changes in locomotor activity, especially this behavioural 
aspect was further investigated. In the first paper of this section the 
effects of local injections of dopamine and noradrenaline are studied in 
rats, pretreated with the monoamine oxidase-inhibitor nialamide. This 
topic is further elaborated in the second paper, which describes the in­
fluence of dopaminergic and noradrenergic antagonists upon these effects. 
Finally, data on the effects of dopamine and other substances (dopamine 
metabolites, dopaminergic and noradrenergic agonists), following injec­
tion into the nucleus accumbens as well as into the tuberculum olfacto-
rium of ηση-pretreated rats, are presented in the third paper of this 
section. 
Section II deals with an attempt to analyse the respective role of 
the mesolimbic and nigro-neostriatal dopamine system with respect to the 
behavioural effects of peripherally administered d-amphetamine and apo-
morphine. In the first paper of this section the influence of injection 
of the dopamine antagonist haloperidol into the nucleus accumbens or the 
caudate nucleus upon d-amphetamine-induced locomotor stimulation is 
studied, whereas this influence upon d-amphetamine- and apomorphine-
-induced stereotyped behaviour is described in the second paper. 
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Section III deals with investigations concerning a class of com-
pounds, known already for a long time, which have more recently received 
renewed interest because of their presumed interaction with dopamine, 
viz. the ergot alkaloids. Several menbere of this class, especially 
ergometrine, have been reported to be potent antagonists of the actions 
of dopamine upon snail neurones (Walker et al., 1968; Woodruff, 1971; 
Struyker Boudier, 1975). It seemed therefore of interest to study the 
influence of ergot alkaloids upon dopaminergic systems in the rat brain. 
The first paper of this section describes the effects seen following 
peripheral administration of ergometrine as well as following injections 
directly into the nucleus accumbens or caudate nucleus. Since the results 
of this study suggested that ergometrine might have dopamine-like pro-
perties in the rat brain, a finding supported by studies concerning 
effects of other ergot alkaloids (Corrodi et al., 1973; Johnson et al., 
1973; Fuxe et al., 1974b), further investigations were performed in 
order to elucidate the discrepancy between the effects of ergot alkaloids 
upon the rat brain and those upon the snail brain. These investigations 
are presented in the second paper of this section. 
13 
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SECTION I 

Stimulation of locomotor activity following injection of 
dopamine into the nucleus accumbens 
Recently we have observed that bilateral injection of ergometrine into the nucleus 
accumbens of rats results in a strong and long-lasting enhancement of locomotor 
activity (Pijnenburg, Woodruff & van Rossum, 1973). This effect was antagonized 
by low doses of haloperidol and pimozide. The hypothesis was proposed that this 
enhanced locomotor activity was elicited by a stimulation of dopamine receptors in 
the nucleus accumbens. 
We now report that administration of dopamine directly into the nucleus accumbens 
of nialamide-pretreated rats produces a pattern of enhanced locomotor activity 
similar to that seen after ergometrine. 
Seven male Wistar rats (200-220 g) were implanted with double barrelled cannulas 
in each side of the nucleus accumbens (coordinates A 9-4, L 1·2 and Η —0-6 accord­
ing to the atlas of König & Klippel, 1963). These animals were used for all experi-
ments with 5-8 days between experiments. The animals were subsequently killed 
and brains were sectioned to determine the position of the cannulas. For details of 
the experimental procedure see Pijnenburg & others (1973). Injections were made by 
means of a 5 μ\ Hamilton syringe with a 31 gauge needle. The injection volume was 
0-5 μί. Dopamine HCl and (—^noradrenaline (—)-hydrogen tartrate were dissolved 
in saline. 
Locomotor activity was measured in activity cages, equipped with photoelectric 
cells and recorded on a cumulative recorder. 
The rats were always pretreated with the monoamine oxidase inhibitor nialamide 
(100 mg kg-1 i.p.) 18 h before administration of saline, dopamine or noradrenaline. 
Injection of dopamine (S fig) to each side of the nucleus produced a strong enhance­
ment of locomotor activity, which started in S animals within 10 min of injection and 
lasted for up to 4 h, reaching a peak at about 1 h returning to 0 over the next 3 h with 
the most rapid decline over the last 30 min. In two rats, in which the injection site 
was found to be at the border of the nucleus accumbens, stimulation of locomotor 
activity started after 20 and 30 min respectively and failed to reach the level seen in 
the other rats. This is probably the reason for the large variability in the results 
(see Table 1). 
Injection of noradrenaline (5-0 .^g) into each side of the nucleus accumbens of the 
same rats produced enhanced locomotor activity in S of the 7 animals but this was 
Table 1. The effect on locomotor activity of injections of dopamine and noradrenaline 
into each side of the nucleus accumbens of the rat. Nialamide 100 mg kg-1 
was given 18 h before the injection of dopamine or noradrenaline (n = 
number of experiments). 
Mean locomotor activity ± s.e. during 
Dose η Ih 2 h 3 h 4 h 
Saline 7 138 ± 28 43 ± 6 35 ± 10 13 ± 5 
Dopamine . . 5 - 0 7 3652 ± 1010· 4672 ± 892» 3884 ±889' 2012 ± 627« 
1-0 7 1344 ± 463^ ^ 784 ± 261« 185 ± 58« 67 ± 25 
Noradrenaline .. 5-0 7 580 ± 232« 1012 ± 413« 689 ± ЗО4 408 ± 18« 
* Ρ < 0 02 both with respect to saline and noradrenaline 50 /ig. 
ь
 Ρ <0·01 both with respect to saline and noradrenaline 5 0 μ%. 
° Ρ <0-02 with respect to saline, Ρ <005 with respect to noradrenaline 5-0 /ig. 
Λ
 Ρ <0·05 with respect to saline. 
Statistical significance calculated according to Student's /-test for paired comparison. 
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significantly less than after the dopamine (SO /¿g) and started after 30-40 min and 
lasted about 4 h. The 2 rats with offset injection sites showed no stimulation of 
locomotor activity after noradrenaline. 
Even a dose of 10 μg of dopamine was effective in S of the 7 rats who responded 
with enhanced locomotor activity within 10 min. The degree of motor activity, 
which was highest during the first hour, was less than after the SO /ag dose and lasted 
for about 2-3 h (see Table 1). The 2 animals with offset injection sites did not 
respond. Injections of saline were ineffective. 
Thus, stimulation of dopamine receptors in the nucleus accumbens results in en­
hanced locomotor activity. The behavioural pattern showed the same characteristics 
as seen after injection of ergometrine, i.e. continuous exploring activity, except that 
the time for the appearance of locomotor stimulation was shorter. 
This finding favours the assumption that ergometrine has dopamine-stimulating 
properties in the rat brain. This is in agreement with observations on some other 
ergot-derivatives. For instance, it was found by Stone (1973) that agroclavine 
produced "stereotyped" sniffing and gnawing behaviour. Corrodi, Fuxe & others 
(1973) found that ergocomine and 2-Br-a-cryptine (CB154) mimicked the action of 
apomorphine in rats with a unilateral 6-hydroxydopamine-induced degeneration 
of the nigro-neostriatal dopamine pathway and produced a decrease in the dopamine 
turnover in the neostriatum and the limbic system; they concluded that the main 
action of these drugs was a direct dopamine receptor stimulation of long duration. 
Several studies have indicated that dopamine might play an important role in the 
motor stimulation seen after injection of psychomotor stimulant drugs (van Rossum & 
Hurkmans, 1964; Maj, & Grabowska & Gajda, 1972; Andén, Strömbom & Svensson, 
1973). Although we would not exclude the role of noradrenaline, it is possible that 
these drugs exert their effect in part via the dopamine system in the nucleus accumbens. 
Bilateral injection of dopamine into the caudate nucleus of nialamide-pretreated 
rats did not result in such a strong locomotor activity. Although with doses of 10 and 
50 jig dopamine there was a slight to moderate increase of motor activity, the pre-
dominant feature was stereotyped sniffing behaviour, which appeared 30-40 min 
after the injection (D. Malee, unpublished). This was not seen in the present experi-
ments which provide evidence that the mesolimbic dopamine system with cell bodies 
in the A 10 group (classification according to Dahlström & Fuxe, 1965) and nerve 
terminals in the nucleus accumbens and tuberculum olfactorium (Andén, Dahlström 
& others, 1966; Arbuthnott, Crow & others, 1970; Ungerstedt, 1971) is functionally 
different from the nigrostriatal dopamine system. 
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Abstract The effects of injections of monoamines, alone 
and in combination with different antagonists, bilaterally 
into the nucleus accumbens of malamide-pretreated rats 
were investigated 
Dopamine was found to produce a stronger stimulation 
of locomotor activity than noradrenaline, whereas serotonin 
was effective only in a small number of animals, in which 
the duration of locomotor stimulation was shorter than after 
dopamine or noradrenaline The effects of both dopamine 
and noradrenaline were completely antagonized by admin­
istration of a small dose of the dopamine antagonist halo-
pendol, administered bilaterally Π nun after the catechol-
Introduction 
Recently we have found that bilateral injection of 
dopamine into the nucleus accumbens of malamide-
pretreated rats resulted in a strong and long-lasting 
enhancement of locomotor activity (Pijnenburg and 
van Rossum, 1973) Stimulation of locomotion was 
also observed following administration of noradrena­
line into this nucleus, although less intense than after 
dopamine 
Both dopamine and noradrenaline are reported 
to be involved in the control of locomotor activity (van 
Rossum, 1970, Svensson and Waldeck, 1970, Anden 
étal, 1973) The main catecholamine in the nucleus 
accumbens of the rat is dopamine (Ungerstedt, 1971, 
Lidbnnk et al, 1974), but the occurrence of nor-
adrenaline in this nucleus is also described (Koob 
etat, 1974) 
It is found that exogenous noradrenaline can be 
taken up in dopaminergic nerve terminals of the cau-
amines The α-adrenergic antagonist phentolamine did not 
inhibit the effect of noradrenaline but, on the contrary, po­
tentiated and considerably prolonged the duration of lo­
comotor stimulation Also, the effect of dopamine was po­
tentiated and prolonged by phentolamine Bilateral 
injection of phentolamine alone had no influence upon lo­
comotor activity The effect of noradrenaline was not clearly 
inhibited nor potentiated by the /^-adrenergic antagonist 
propranolol It is suggested that the stimulation of locomotor 
activity induced by injection of noradrenaline into the nu­
cleus accumbens of malamide-pretreated rats is brought 
about via dopaminergic mechanisms 
date nucleus and nucleus accumbens (Masuoka and 
Alcaraz, 1973) The question therefore anses, wheth­
er the locomotor stimulant action of noradrenaline 
following its injection into the nucleus accumbens is 
brought about by an action on noradrenaline receptors 
or by stimulation of dopamine receptors, in which case 
the noradrenaline should act by displacement and 
subsequent release of dopamine or by an interaction 
with dopaminergic receptors 
We have tried to investigate this problem by as­
suming that, when noradrenaline should act via do­
paminergic receptors, its effect could be blocked by 
dopamine antagonists but not by noradrenaline antag­
onists If, on the other hand, noradrenaline should act 
via noradrenergic receptors, then it should be possible 
to antagonize the effect of noradrenaline by nor­
adrenaline antagonists, but not by dopamine antag­
onists 
Furthermore the effect of injection of serotonin 
into the nucleus accumbens of malamide-pretreated 
Key words Dopamine - Noradrenaline - Nialamide - Nucleus Accumbens - Locomotor Achvity - Haloperidol - Phentol­
amine - Propranolol 
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animals was studied, because this amine is supposed 
to be involved in the increased motor activity of an­
imals following nialamide (Modigh and Svensson, 
1972). 
Methods 
Surgery Male Wistar rats were used, weighing 200 ± 
20 g at the time of operation Under sodium pentobarbital 
anesthesia (40 mg/kg ι ρ ), double barrelled stainless steel 
cannulae were stereotaxically implanted into the nucleus ac-
cumbens on both sides The following coordinates were cho­
sen for the mjecuon-site according to the atlas of König 
and Klippel (1963) A 9 4,L1 2 a n d H - 0 6 Thecannulae, 
which had an outer and inner diameter of 0 65 mm and 0 30 
mm respectively, were brought in from the lateral side at 
an angle of 10° with the midline in order to avoid the ven-
tricular system and fixed on to the skull with acrylic dental 
cement (Paladur·) 
Following surgery the animals were housed individually 
with food and water ad libitum 
Illumination was present from 6 0 0 a m to 6 00 ρ m 
A period of at least 10 days was given for recovery before 
the start of the experiments During this time the rats were 
accustomed to handling and could adapt to the activity cages 
Apparatus Locomotor activity was measured in activity 
cages equipped with 3 light sources and opposite to Ihem 
3 photoelectric cells, 2 cm above a grid floor The dimen­
sions of the cages were 36 cm X 24 cm x 25 cm The cages 
were situated in a ventilated sound-proof box The inter­
ruptions of the light beams were automatically registered 
on a cumulative Ralph-Gerbrands recorder 
Procedure In all experiments the monoamine oxidase-m-
hibitor nialamide (100 mg/kg ι ρ ) was given 18 hrs before 
injections into the brain The expenments were started at 
9 00 a m After an adaptation penod to the activity cages 
of about one hour for each experiment locomotor activity 
was measured during at least 5 hrs following the central in­
jection of dopamine, noradrenahne or serotonin In­
tracerebral injections were given bilaterally by means of a 
5 μΐ Hamilton synnge with a 31-gauge needle, which ex­
tended into the brain tissue 1 0-1 5 mm below the tip of 
the permanently implanted cannula 
The injection volume was always 0 5 μΐ The dopamine 
antagonist halopendol and the a-resp Д-adrenergic antag­
onists phentolamine and propranolol were administered 15 
mm after injection of dopamine and noradrenaline This 
time of injection was chosen in order to be certain that these 
antagonists were acting when locomotor stimulation was 
present, since there was in general a rather long time of 
latency before the animals started to run Since the same 
animals were used, at least one week of rest was given be­
tween the different experiments 
Drugs The following drugs were used dopamine 
hydrochloride (Koch-Light Lab ), /-noradrenaline bitar­
trate (Koch-Light Lab ), serotonin creatinine sulfate (Fluka 
A G ) , phentolamine methanesulfonate (Regnine®, Ciba), 
/-propranolol ( I C I ) , halopendol (Serenase®, Janssen 
Pharm ) and nialamide (Pfizer) 
The doses refer to the salts except for the three last 
mentioned drugs All drugs were dissolved m a 0 9 % saline 
solution, except the commercial preparations Serenase® and 
Regione* which were given as such Saline was used as 
a control 
Statistics Statistical comparison between different treat­
ments was made using Student's r-test for paired compan-
son Two-tailed probability values are reported 
Histology At the end of the expenments the rats were per­
fused with saline and a 10% formalin solution through the 
left cardiac ventnde under sodium pentobarbital anesthesia 
The brains were removed and kept in a 4% formalin 
solution for at least 7 days and were then sectioned for con­
trol of the site of injection 
Results 
Injection of Monoamines The effects of injections of 
different monoamines bilaterally into the nucleus ac-
cumbens of nialamide-pretreated rats upon locomotor 
activity are shown in Table 1 Administration of 5 μg 
of dopamine resulted in all animals in a strong stim­
ulation of locomotor activity, which lasted for about 
5 hrs In this group of animals, however, the time of 
latency with regard to the start of locomotor stim­
ulation following the injection was in general some­
what longer than previously found (Pijnenburg et al, 
1973) The locomotor activity was significantly en­
hanced dunng the second, third and fourth hour as 
compared to sahne Injection of 5 μg of noradrenaline 
also produced locomotor stimulation, which lasted 
about as long as following injection of 5 μg of dopa­
mine, but was less intense Following serotonin (5 μ§) 
2 of the 9 animals showed a strong stimulation of lo­
comotor activity, which lasted for about 2 hrs In a 
third animal there was a moderate stimulation during 
the first hour, while in the remaining rats no stim­
ulation at all was seen Dopamine in a dose of 1 fig 
was also effective, although the locomotor activity was 
not as high as following the S μg dose The duration 
of the effect was also shorter, lasting for about 3—4 
hrs A dose of 1 μg of noradrenaline produced only 
slight locomotor stimulation, mainly dunng the second 
hour following injection 
Effects of Antagonists upon Dopamine-lnduced Stim­
ulation In these expenments a dose of 1 μg of dopa­
mine was given, followed 15 mm later by an injection 
of saline or one of the used antagonists (see Table 
2) When saline (0 5 μΐ) was injected after dopamine 
a clear reduction of activity was found, which was most 
conspicuous dunng the second and third hour 
(P < 0 10) The effects of drugs, therefore, were com­
pared with this effect of saline 
The dopamine antagonist halopendol in a dose 
of 2 5 μg completely antagonized the effect of 1 μ§ 
of dopamine The effect of 5 μ§ of dopamine was 
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Table 1 Locomotor activity of rats following injection of different substances bilaterally into the nucleus accumbens Nialamide 
(100 mg/kg ι ρ ) was given 18 hrs earlier Results are «pressed as mean number of light beam-interruptions per time-penod 
± S Ε Μ π = number of animals Symbols reflect significant differences in compansoo with sahne Symbols within brackets 
refer to comparison with noradrenaline 5 Mg Levels of significance · ί , < 0 0 5 , · · ί » < 0 0 1 , · · · Ρ < 0 0 0 1 
Drug Dose 0-60 mm 60-120 nun 120-180 mm 180-240 mm 240-300 mm 
Saline 
Dopamine 
Noradrenaline 
Serotonin 
Dopamine 
Noradrenaline 
Phentolamine 
5 Mg 
5 Mg 
5 Mg 
iMg 
1 Mg 
5 Mg 
185 ± 24 
1357 + 685 
492 ± 155 
967 ±450 
2188 ± 707* 
134 ± 42 
150 ± 35 
101 ± 21 
4185 ± 585· · · 
2416 + 667·· 
912 ± 459 
2318 ± 654·· 
231 ± 67· 
105 ± 22 
97 ± 22 
455Э ± 773 · · · < · · · 
1560 ± 524· 
202 ± 105 
1535 ± 472* 
176 ± 56 
117 + 38 
118 ± 21 
3136 ± 902 
939 ± 401 
83 ± 27 
301 ± 84 
122 ± 49 
137+ 61 
9 4 ± 22 
1472 ± 727 
668 ± 248· 
74 ± 
190 ± 
105 ± 
103 ± 
Table 2 Locomotor activity of rats following injection of 1 Mg of dopamine, 15 mm later followed by injection of different sub­
stances bilaterally into the nucleus accumbens Nialamide (100 mg/kg ι ρ) was given 18 hrs earlier Results are expressed as mean 
number of light beam-interruptions per time-period + S Ε Μ π = number of animals Statistical companson was made with 
injection of saline 15 mm after dopamine Levels of significance * Ρ < 0 05, · · Ρ < 0 01 
Drug 15 mm 
after Dop­
amine 1 Mg 
No drug 
Saline 
Haloperidol 
Phentolamine 
Propranolol 
Dose 
2 5 μ 8 
5 Mg 
5Mg 
η 
9 
9 
9 
8 
8 
0-15 mm 
437 ± 134 
370 ± 96 
371 ± 124 
380 + 171 
247 ± 65 
15-60 mm 
1715 ± 583 
1228 ± 349 
157 ± 47· · 
981 ± 358 
570 ± 231 · 
60-120 mm 
2318 + 654 
1239 ± 353 
89 ± 26· · 
2535 ± 940 
974 ± 546 
120-180 mm 
1535 + 472 
506 ± 124 
59 ± 16·· 
1555 ± 621 
507 ± 286 
180-240 mm 
3 0 1 + 8 4 
278 ± 53 
59 ± 18·· 
1248 ± 655 
188 ± 70 
240-300 mm 
190 ± 48 
114 ± 21 
76 ± 20 
716 ± 382 
149 ± 65 
markedly reduced by this dose of halopendol but not 
completely antagonized (not shown) Administration 
of the α-adrenergic antagonist phentolamine in a dose 
of 5 μg did not inhibit the effect of dopamine but, on 
the contrary, intensified it although the values for the 
activity did not reach levels of significance Moreover, 
the duration of locomotor stimulation was prolonged, 
lasting in several animals for about 7 or 8 hrs In con­
trast to the injection of dopamine alone, with which 
the animals often showed a rather sudden finish of 
locomotor stimulation, there was a more gradual sub­
siding of activity when phentolamine was given after 
dopamine A similar potentiation was found when 
phentolamine (S Mg) was administered 20 mm before 
dopamine instead of 15 mm later (not shown) 
Upon administration of the /9-adrenergic antag­
onist propranolol (5 Mg) no clear change of activity 
was found except for an inhibition during the first 45 
min following injection of this drug 
Effects of Antagonists upon Noradrenahne-lnduced 
Stimulation As 1 Mg of noradrenaline hardly produced 
locomotor stimulation, a dose of 5 Mg was adminis­
tered in these experiments followed 15 mm later by 
injection of saline or another drug (see Table 3) As 
in the experiment with dopamine a considerable re­
duction of activity was found when saune (0 5 μΙ) was 
injected 15 min after noradrenaline During the sec­
ond hour following injection there was a significant 
difference with noradrenaline alone When compared 
with the effect of saline, halopendol in a dose of 2 5 
Mg showed a clear inhibition of the stimulation of lo­
comotor activity induced by noradrenaline Adminis­
tration of phentolamine (5 Mg) 15 mm after nor­
adrenaline did not result in an inhibition of the effect 
of noradrenaline but, instead, produced a potentia­
tion, which was even more clear than after dopamine 
The duration of locomotor stimulation was prolonged 
in most animals, lasting in two rats for about 14 hrs 
and in one rat even for 20 hrs, although the intensity 
gradually diminished Injection of phentolamine 
alone, without dopamine or noradrenaline, in niala-
mide-pretreated rats did not produce any stimulation 
of locomotor activity (see Table 1) No significant 
changes of locomotor activity were found on adminis­
tration of 5 pg of propranolol 15 mm after noradrena­
line In general the activity was slightly higher than 
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Table 3 Locomotor activity of rats following injection of 5 Mg of noradrenaline, 15 nun later followed by injection of different 
substances bilaterally into the nucleus accumbens Nialamide (100 mg/kg ι ρ ) was given 18 hrs earlier Results are expressed 
as mean number of light beam-intermptions per time-period + S Ε M л = number of animals Statistical companson was made 
with injection of saline 15 mm after noradrenaline Level of significance 'P<0 05 
Drug 15 min Dose 
after Nor­
adrenaline 5 \ig 
No drug — 
Sahne 
Haloperidol 2 5 Mg 
Phentolamine 5 Mg 
Propranolol 5 Mg 
π 
9 
8 
9 
9 
8 
0-15 mm 
ПО ± 28 
118 ± 44 
154 ± 55 
174 ± 49· 
212 + 108 
15-60 min 
382 ± 143 
113 ± 33 
118 ± 26 
380 ± 185 
377 + 229 
60-120 mm 
2416 ± 667· 
554 ± 149 
116 ± 33· 
2219 ± 661 
1273 ± 739 
120-180 min 
1560 ± 524 
776 ± 269 
86 ± 22· 
3413 ± 954· 
874 ± 405 
180-240 min 
939 + 401 
498 ± 238 
110 ± 23 
2789 ± 680* 
590 ± 369 
240-300 min 
668 ± 248 
282 ± 112 
95 ± 17 
2246 ± 586· 
349 ± 186 
following administration of saline after noradrenaline 
Histology The position of the tip of the needle-tracks 
was found in all animals within the boundanes of the 
nucleus accumbens, as depicted in the atlas of König 
and Klippel (1963) In six rats the placement was 
found in or between the anterior planes 9410 μ and 
9650 μ In two animals a more antcnor placement was 
found (antenor plane 9820 μ) and in one animal a 
more postenor placement (near plane 8920 μ) 
The lateral coordinates varied from 0 6 to 14, 
whereas the horizontal coordinates ranged from - 0 2 
to - 1 0 
Discussion 
The results of injections of dopamine and noradrena-
hne bilaterally into the nucleus accumbens of mala-
nnde-pretreated rats confirm our previous findings 
(Pijnenburg et al, 1973) and show that dopamine pro­
duces a stronger stimulation of locomotor activity than 
noradrenaline upon bilateral injection into this nu­
cleus 
Injection of sahne IS mm after dopamine or nor­
adrenaline considerably reduced the effect of these 
catecholamines It is possible that by the adminis­
tration of saline a dilution of the exogenously applied 
dopamine and noradrenaline is brought about, result­
ing in a diminished effect 
The locomotor stimulation induced by 1 Mg of 
dopamine was completely blocked by halopendol The 
same dose of halopendol also completely inhibited the 
effect of 5 Mg of noradrenaline Halopendol is consi­
dered as a rather specific dopamine antagonist both 
peripherally and centrally (van Rossum, 1966, Yeh 
et al, 1969, Janssen étal, 1965), with only relatively 
small effects on noradrenaline receptors (Anden et al, 
1970) Since a rather low dose was used, the effect 
of halopendol upon the dopamine and noradrena-
hne-induced locomotor stimulation may be asenbed 
to a blockade of dopamine receptors, the more so as 
more specific noradrenaline antagonists did not inhibit 
the locomotor stimulation 
A surprising finding in this study was the fact that 
the α-adrenergic antagonist phentolamine potentiated 
the stimulation of locomotor activity induced by nor-
adrenahne and dopamine and considerably prolonged 
the duration of this effect At present we have no good 
explanation for this interesting phenomenon Al­
though one might consider a dual action of the cate­
cholamines or an action of phentolamine on pre­
synaptic σ-receptors (Starke, 1972, Starke and 
Montel, 1973a, 1973b, Langer, 1974, Westfall, 
1974), a mechanism of action of phentolamine, not 
related to its α-adrenergic blocking action cannot be 
excluded A satisfactory explanation of this phenome­
non therefore must await further experiments 
The ¿{-adrenergic blocking agent propranolol did 
not clearly potentiate nor inhibit the effect of nor-
adrenahne 
The locomotor activity induced by dopamine, 
however, was lower during the first 45 mm following 
the injection of propranolol than following saline In 
biochemical expenments it was found that propranolol 
did not antagonize the stimulation of adenylate 
cyclase in the nucleus accumbens by dopamine, 
whereas phentolamine weakly antagonized this effect 
(Horn et al, 1974) A similar effect of propranolol 
and phentolamine was also found upon a dopamine-
sensitive adenylate cyclase in the caudate nucleus 
(Kebabian era/, 1972) In behavioural expenments 
it was earlier found that dopamine receptors in the 
rat caudate nucleus were not antagonized by the ß-
adrenergic blocker propranolol whereas a-adrencrgic 
blocking agents had little if any effect (Anden era/, 
1966) It is therefore doubtful whether the diminished 
locomotor activity can be asenbed to an action of pro-
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pranolol on dopamine receptors Since the noradrena-
hne-mduced locomotor activity was not inhibited by 
propranolol, it might be possible that the value found 
for the first 45 min following propranolol was signifi­
cantly lower than following saline only by chance, 
which is probably also the case for the value found 
in the first IS mm following noradrenabne before 
phentolamine was given 
Since the locomotor stimulation induced by nor­
adrenaline was blocked by the dopamine antagonist 
halopendol, but not by the noradrenaline antagonists 
phentolamine and propranolol, it is likely that the ef­
fect of noradrenaline was brought about via dopami­
nergic mechanisms It is interesting to mention that 
Geyer et al (1972) came to opposite conclusions on 
the basis of expenments with intraventricular in­
fusions of dopamine and noradrenaline They sug­
gested that the stimulation of activity produced by 
dopamine, as found in their study, was due to ex­
citation of noradrenergic receptors It might therefore 
be conceivable that the effects of centrally applied 
drugs are dependent upon the site of injection, since 
they made use of intraventricular infusions and there­
fore possibly reached different parts of the brain, 
whereas in our study injections were performed, which 
were more restneted to a dopamine-nch structure 
No attempt was made to investigate the action of 
different antagonists upon the locomotor activity in­
duced by serotonin, because only a few animals 
showed locomotor stimulation Since it is known that 
serotonin can be taken up in dopaminergic nerve ter­
minals too (Iversen, 1974) it is possible that this effect 
of serotonin is also brought about by an action via 
dopaminergic receptors 
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The effects of local injections of drugs into terminal areas of the mesohmbic dopamine system were investi 
gated Bilateral administration of dopamine, but not of noradrenaline and serotonin, into the nucleus accumbens 
of non prelreated rats resulted in stimulation of locomotor activity No clear or only minor effects were seen 
after injections of the dopamine metabolites 3 methoxytyramine, DOPAC and HVA and after injections of media 
with different pH and osmolality d-Amphetamine proved more effective than dopamine in producing locomotor 
stimulation, whereas both stimulant and depressant effects were observed following injection of apomorphine 
into the nucleus accumbens ET 495 and the noradrenaline agonists Clonidine, phenylephrine and isoprenahne did 
not enhance locomotor activity, but theophylline was effective Pretreatment with halopendol, but not with 
clozapine, significantly reduced the effects of dopamine and theophylline Locomotor stimulation was also found 
following bilateral administration of dopamine, d amphetamine and apomorphine into the tuberculum olfacto 
num, whereas noradrenaline, serotonin and ET 495 produced no, or rather depressant effects These results 
provide further evidence for an important role of the mesohmbic dopamine system with respect to locomotor 
activity 
Dopamine Nucleue accumbens Tuberculum olfactonum Locomotor activity 
1. Introduction 
Histochemical fluorescence studies have re-
vealed the existence of two major ascending 
dopaitiine systems in the rat brain. In addition 
to the well-known mgro-neostnatal pathway, a 
smaller system is described, the so-called meso-
hmbic dopamine system (Ungerstedt, 1971). 
Axons arising from cell-bodies in the ventral 
mesencephalic tegmentum, dorsocramally to 
the nucleus interpedunculans (A-10 group ac-
cording to Dahlstrom and Fuxe (1965)) follow 
a route medial from the mgro-neostnatal sys-
tem and enter the nucleus accumbens, the 
tuberculum olfactonum and the nucleus inter-
stitialis striae termmalis. Recent studies have 
provided evidence that these dopaminergic sys-
tems, originating in the ventral mesencephalon, 
have a wider distribution than previously sup-
posed and send axons not only to subcortical 
areas, but also to the cerebral cortex (Lindvall 
and Bjorklund, 1974, Lindvall et al., 1974, 
Fuxe et al., 1974). 
Measurements of monoamine levels in small 
microdissected brain areas with enzymatic iso-
topie methods or mass fragmentography have 
confirmed the presence of high concentrations 
of dopamine in the nucleus accumbens and 
tuberculum olfactonum (Brownstein et al, 
1974, Koslow et al, 1974). Noradrenaline 
concentrations are relatively low in these areas, 
whereas rather high levels of serotonin are 
found in the tuberculum olfactonum (Saavedra 
et al, 1974). In addition to dopamine, both the 
nucleus accumbens and the tuberculum olfac-
tonum have been found to be very rich in 
acetylcholine and the enzymes acetylcholin-
esterase and cholmeacetyltransferase (Lewis 
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and Shute, 1967; Palkovits et al., 1974; Koslow 
et al., 1974). 
Although these limbic forebram areas are 
histochemically very similar to the neostna-
tum, several behavioural and biochemical 
studies have revealed differences between the 
nigro-neostriatal and the mesohmbic dopamine 
system (Pijnenburg and Van Rossum, 1973; 
Pijnenburg et al., 1973, 1975a, Anden, 1972, 
1974, Andén and Stock, 1973; Stevens étal., 
1974). For a better understanding of the ef-
fects of drugs which interfere with dopaminer-
gic systems in the bram, e.g. anti-Parkinson and 
antipsychotic drugs, more information con-
cemmg the role of each of these systems is 
important. We had previously found that dop-
amine, and to a lesser degree noradrenaline, 
produced a strong locomotor stimulation fol-
lowing injection into the nucleus accumbens of 
rats pretreated with nialamide (Pijnenburg et 
al., 1973). Since nialamide interferes not only 
with dopamine, but also with other substances 
m the brain, the present study was performed 
in order to investigate whether dopamine 
would also be effective without nialamide-pre-
treatment and to determine the specificity of 
its action. Moreover, we wanted to investigate 
whether injections of dopamine into the tuber-
culum olfactonum would also produce loco-
motor stimulation. 
2. Materials and methods 
2 1 Animals 
Male Wistar rats, weighing 200 ± 20 g at the 
tune of surgery, were used throughout all 
experiments. 
2 2 Intracerebral injections 
Double barrelled stainless steel cannulae 
with an outer and inner diameter of 0.65 and 
0.30 mm resp. were stereotaxically implanted 
into the nucleus accumbens and the tuber-
culum olfactonum on both sides. The injection 
sites chosen for the nucleus accumbens had the 
following coordinates, according to the atlas of 
König and Klippel (1963): A 9.4, L 1.2 and H 
—0.6 and those for the tuberculum olfacto-
num: A 8.4, L 2.0 and H —2.4. Prelimmaiy 
expenments had revealed that slight modifica-
tions of these coordinates were necessary to 
reach the intended injection sites, probably 
because these rats had a greater body-weight 
than the rats used m the atlas (Modified coor-
dinates: nucleus accumbens A 9.8, L 1.2, 
H—2.2, tuberculum olfactonum- A 8.8, L 2.0, 
H—3.8) In order to avoid the ventricular sys-
tem, cannulae were brought in from the lateral 
side. An angle of 10° with the mid-sagittal 
plane was used for implantation mto the nu-
cleus accumbens, while cannulae for the tuber-
culum olfactonum were implanted at an angle 
of 5°. In the latter case an attempt was made to 
lower the cannulae lateral from the nucleus 
accumbens. After placement the cannulae were 
fixed to the skull with acrylic dental cement 
(Paladur). Following surgery the animals re-
ceived Oxytetracycline (Terramycine® ) in their 
drinking water for a penod of 5 days. The rats 
were housed thereafter in individual cages with 
free access to food and water. Illumination was 
present from 6.00 a.m. to 6.00 p.m. 
The expenments were started after a penod 
of 10 days, during which time the rats were 
accustomed to handling and to the injection 
procedure and during which time they were 
adapted to the activity cages. Intracerebral 
injections were given to the unanaesthetized 
animals by means of a 5 μΐ Hamilton syringe 
with a 31 gauge needle, which extended mto 
the brain tissue 1.0—1.5 mm below the tip of 
the permanently implanted cannula. The injec­
tion volume was always 0.5 μΐ on each side, 
unless indicated otherwise and this volume was 
infused during a penod of 10 sec. Within each 
expenment, treatments were given in a rando­
mized sequence. At least two days of rest were 
allowed between the different treatments. 
2 3 Measurement of locomotor activity 
Locomotor activity was measured in activity 
cages equipped with 3 light sources and op-
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posite to them, 3 photoelectric cells 2 cm above 
a gnd floor. The dimensions of the cages were 
36 X 24 X 26 cm. The cages were situated m a 
ventilated sound-proof box. The interruptions 
of the lightbeams were registered on a cumula­
tive Ralph—Gerbrands recorder Only one ani­
mal at a time was placed m a cage. All expen-
ments were started at the same tune of the day 
(9 00 a.m.). After a period of 1 hr for adapta­
tion to the activity cages, locomotor activity 
was measured during at least 2 hr following the 
intracerebral injection. 
2 4 Statistics 
Statistical comparison between different 
treatments m the same animals was made using 
the paired t-test. Two-tailed probability values 
are reported. 
2 S Histology 
At the end of the experiments, 0.5 μΐ of an 
ink solution was injected to verify the site of 
injection The rats were perfused with saline 
and a 10% formalin solution through the left 
cardiac ventricle under sodium pentobarbital 
anaesthesia. The brains were removed and kept 
m a 4% formalin solution for at least 7 days and 
were then sectioned for control of the site of 
injection. 
2 6 Drugs 
The following drugs were used, dopamine 
hydrochloride (Koch—Light Lab),L-noradren· 
ahne bitartrate (Koch—Light Lab), serotonin 
creatinine sulfate (Fluka AG), 3-methoxy-
tyramine hydrochloride (Sigma), 3,4-dihy· 
droxyphenylacetic acid cyclohexylamme salt 
(DOPAC, Calbiochem); homovamUic acid 
(HVA, Calbiochem), d-amphetamme sulfate, 
apomorphme hydrochloride (Brocades—ACF); 
Clonidine hydrochloride (Boehnnger Ingel­
heim), 1-isoprenalme hydrochloride; 1-phenyl-
ephrme hydrochloride, carbaminoylcholine 
chloride (carbachol), ET 495 (pinbedil), theo­
phylline, halopendol (Serenase*, Janssen Phar-
maceutica), clozapme (Sandoz AG). The doses 
used refer to the salts where these are men­
tioned. Saline was used as solvent for intra­
cerebral injections, except m the case of ET 
495, which was dissolved m distilled water and 
of apomorphme hydrochloride, which was 
used as a commercial preparation. In addition 
the effects of solutions with different pH and 
osmolality were investigated, as further de­
scribed under Results. 
3. Results 
3 1 Injections into the nucleus accumbens 
3 11 Injection of monoamines 
The effects of injections of dopamine, nor­
adrenaline and serotonin m doses of 1, 5 and 10 
μg bilaterally into the nucleus accumbens upon 
locomotor activity are shown m table 1. The 
high activity after bilateral injection of saline 
durmg the first 15 mm compared to the activity 
during the following periods reflects the ex­
ploratory behaviour of the rats following ma­
nipulation and replacement in the cage In 
comparison with salme, injection of dopamine 
m a dose of 1 μg bilaterally produced no 
clearcut effects Administration of 5 and 10 Mg 
dopamme, however, resulted m a strong stimu­
lation of locomotor activity, lasting for about 
half an hour and 45 mm resp In most animals 
the effect appeared within 5 mm following 
injection and a rather sudden finish of activity 
was often noted (see fig 1) The locomotor 
activity consisted mainly of coordinated move­
ments, resembling exploratory behaviour with 
much running and rearing, accompanied by 
sniffing Also occasionally jumpmg and signs of 
excitement, like exophthalmus and defaeca-
tion, were noted. 
Injections of noradrenaline and serotonin m 
the same animals did not produce locomotor 
stimulation. On the contrary, a reduction of 
activity was found durmg the first 15 mm 
following the injection with the highest doses 
having the strongest effect. 
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TABLE 1 
The effect of injections of different doses of dopamine, noradrenaline, serotonin and d-amphetamine bilaterally 
into the nucleus accumbens upon locomotor activity. Saline was used as a control. In this and the following tables 
locomotor activity is expressed as the number of light beam interruptions at different time-intervals after injec­
tion (time 0). Means ±S.E.M. are given, η = number of rats. Levels of significance' * p < 0.05; **p < 0.01; 
*** ρ < 0.001 with respect to saline. 
Drug 
Saline 
Dopamine 
Noradrenaline 
Serotonin 
l-Amphetamine 
Dose 
(№) 
-
1 
5 
10 
1 
5 
10 
1 
S 
10 
1 
6 
10 
η 
18 
18 
18 
18 
18 
18 
18 
18 
18 
18 
18 
18 
18 
0-15 min 
220 t 
2 4 5 ι 
500 t 
464 t 
161 ± 
175 ± 
111 ± 
157 t 
1 5 9 i 
126 t 
667 t 
1068 1 
11911 
24 
25 
69** 
107·» 
21* 
37 
2 8 · * 
13** 
12»» 
16*** 
1 4 1 · * 
142*** 
1 4 2 « · · 
15—30 min 
4 2 i 
43 ι 
294 t 
552 t 
4 9 i 
4 1 t 
34 t 
49 t 
4 7 i 
23 t 
3 4 7 i 
699 ι 
805 t 
9 
11 
5 9 · · · 
1 3 6 · · 
14 
13 
12 
11 
11 
7 
137· 
1 2 4 · · · 
1 3 2 · » · 
30—46 min 
25 t 
42 t 
47 ι 
2 4 9 i 
2 5 i 
63 t 
65 t 
10 t 
18 t 
23 t 
1 7 0 i 
234 t 
356 t 
7 
12 
21 
8 9 · 
7 
18 
25 
6 
5 
6 
72 
5 1 · · · 9 1 * · 
45—60 min 
25 t 
20 t 
2 1 t 
36 ι 
18 ι 
2 5 i 
3 5 i 
27 ι 
28 ι 
7± 
73 t 
76 t 
174 t 
8 
6 
7 
14 
6 
7 
11 
10 
10 
2* 
41 
26* 
64* 
60—120 min 
66 t 15 
46 t 13 
37 t 7 
78 t 21 
4 7 i 8 
62 t 13 
134 ι 40 
61 ι 27 
6 1 1 11 
49 ι 10 
87 t 42 
68 ι 16 
109 t 21 
3.1.2. Injection of dopamine metabolites 
In order to investigate whether the loco­
motor stimulation following injection of dop­
amine was caused by dopamine itself or by its 
metabolites, the dopamine metabolites 3-
methoxytyramine, dihydroxyphenylacetic 
acid (DOPAC) and homovanillic acid (HVA) 
were locally applied. As can be seen from table 
2 none of these compounds produced a loco­
motor activity comparable with that following 
injection of dopamine. Only administration of 
DOP AC resulted in a slight enhancement of 
TABLE 2 
The effect of injections of dopamine and dopamine metabolites bilaterally into the nucleus accumbens upon loco­
motor activity. Mean numbers of interruptions 1S.E.M. are given, η " number of rats. Levels of significance: 
* ρ < 0.05; *** ρ < 0.001 with respect to saline. 
Drug 
Saline 
Dopamine 
3-Methoxytyramine 
DOPAC 
HVA 
Dose 
Ш 
-
10 
5 
10 
5 
10 
10 
η 
8 
8 
8 
8 
8 
8 
8 
0—16 min 
159 t 53 
710 t 7 8 * · · 
171 t 39 
161 ι 34 
254 t 23 · 
250 t 23 
146 t 29 
15—30 min 
6 3 i 20 
713 ι 6 7 · * * 
44 ι 16 
29 t 7 
60 ι 14 
76 t 12 
9 7 i 28 
30—45 min 
20 t 8 
161 t 68* 
31 t 12 
50 t 14 
31 t 19 
23 t 8 
36 t 14 
4 5 - 6 0 min 
18 t 
3 0 i 
21 t 
2 0 i 
19 ι 
1 6 t 
18 t 
9 
9 
7 
9 
5 
4 
12 
6 0 - 1 2 0 min 
46 t 17 
9 2 i 32 
69 ι 17 
68 1 24 
55 t 16 
59 t 14 
7 6 i 41 
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N U C L E U S A C C U M B E N S 
R A T 1 0 2 
S A i I N C 0 S μ| B I L A T 
' D O P A M I N E 10 μ
α
 B I L A T 
d - A M P H E T A M I N E β μο B I L A T 
activity was investigated. Solutions with pH 3 
and pH 10 were prepared from a 0.9% saline 
solution by adding 0.1 N HCl or 0.1 N NaOH 
respectively until the desired pH was reached 
(the pH of the drug solutions used varied from 
2.7 for HVA to 6.9 for d-amphetamme). For 
solutions with different osmolality, distilled 
water and a 1.8% NaCl solution were used in 
addition to saline (0.9% NaCl). Table 3 shows 
that the locomotor activity following injection 
of these solutions was not significantly differ­
ent from that after normal saline. 
Also the influence of pH and osmolality 
upon the effect of dopamine was investigated. 
Smce dopamine appeared to be unstable in a 
pH 10 medium, a pH 8 solution was used m this 
case. As can be seen from table 4 there was no 
clearcut influence of osmolality upon the ef­
fect of 10 μg of dopamine. A low pH did not 
alter this effect either, but alkalimzation re­
sulted in some reduction of the activity. 
I ГЛ» 
* A P O M O f t P H I N E 10 μα B I L A T 
Fig 1 Locomotor activity (cumulative recording) of 
one rat following injection (at arrows) of different 
substances bilaterally into the nucleus accumbens 
Note the rather abrupt finish of locomotor stimula 
tion, which is especially clear in this animal after d-
amphetamine In this rat no clear enhancement of 
activity was seen following administration of 10 /ig of 
apomorphine 
activity dunng the first 15 min. Both 5 Mg and 
lOMg of DOP AC produced this stimulation, the 
effect of 5 μg being just significant. 
3 i 3 Influence of pH and osmolality 
Since it is possible that changes m pH or 
osmolality may influence the activity of neu­
rons, the effect of injections of solutions with 
different pH and osmolality upon locomotor 
3 14 Effects of halopendol and clozapine 
upon dopamine-induced locomotor stimula­
tion 
Pretreatment with the dopamine antagonist 
halopendol in a dose of 0.2 mg/kg i.p., 10 mm 
before the intracerebral injection, clearly re­
duced the locomotor stimulation induced by 
10 ßg of dopamine (table 5). Although the 
locomotor stimulant effect of dopamine was 
also somewhat diminished after pretreatment 
with clozapine in a dose of 2 mg/kg ι p. 10 mm 
before the intracerebral injection, this reduc­
tion was not significant. 
3 7 5 Injection of dopaminergic and other 
stimulants 
d-Amphetamme proved very effective in 
producing locomotor stimulation. A dose of 1 
Mg bilaterally was sufficient to induce a strong 
effect (table 1). Administration of doses of 5 
and 10 Mg resulted in activity which was con­
siderably higher than that seen following dop­
amine and lasted for about 1 hr. 
The effect of the dopamine agonist apomor­
phine was more complex. Both stimulation and 
depression of activity were found after injec-
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TABLE 3 
The effect of injections of media with different pH and osmolality bilaterally into the nucleus accumbens upon 
locomotor activity Mean numbers of interruptions ±S Ε M are given η » number of rats 
Solution η 0—15 min 15—30 min 30—46 mm 46—60 min 60—120 min 
0 9% NaCI (salme) 
Distilled water 
1 8% NaCI 
pH 3 solution 
pH 10 solution 
8 
8 
8 
8 
8 
1 5 9 i 53 
187 t 42 
169 ι 38 
l i l i 26 
157 t 36 
63 ι 20 
78 t 24 
7 2 i 11 
3 9 i 9 
40 ι 10 
2 0 i 8 
2 7 i 8 
1 9 i 11 
3 i 2 
6 i 2 
18 ι 9 
13 ι 8 
2 8 i 18 
1 6 i 8 
6 i 3 
4 6 i 17 
6 8 i 25 
104 t 36 
61 ι 10 
3 4 i 7 
TABLE 4 
The influence of media with different pH and osmolality upon locomotor stimulation, induced by bilateral Injec­
tion of dopamine into the nucleus accumbens. Mean numbers of interruptions ±S Ε M are giren η • number of 
rats Levels of significance * ρ < 0 05 with respect to dopamine dissolved m normal saline 
Dopamine 10 /ig 
dissolved in 
0 9% NaCI (saline) 
Distilled water 
1 6% NaCI 
pH 3 solution 
pH 8 solution 
η 
8 
8 
8 
8 
8 
0—16 mm 
710± 78 
7 4 2 i 110 
785 ι 190 
788 1 157 
5 3 2 i 136 
15—30 mm 
7 1 3 i 67 
6661 97 
6 7 2 i 141 
6 2 2 i 116 
368 ι 149» 
30—46 mm 
161 ι 58 
131 ι 33 
213 ι 64 
154 ι 60 
165 i 98 
45—60 min 
3 0 i 9 
18 t 7 
Б9і 23 
43 ι 15 
10 ι 2 
6 0 - 1 2 0 mm 
92 ι 32 
40 ι 16 
82 ι 22 
8 0 i 24 
3 4 i 7 
TABLE 5 
The effect of pretreatment with helopendol and clozapine upon locomotor stimulation, induced by bilateral in­
jection of dopamine into the nucleus accumbens Mean numbers of interruptions IS Ε M are given π - number 
of rats Haloperidol (0 2 mg/kg ι ρ ) and clqzapine (2 mg/kg ι ρ ) were given 10 min before the intracerebral in­
jection Levels of significance **p < 0 01, ***p < 0 001 with respect to saline, · · ρ < 0 01, *** ρ < 0 001 with 
respect to the effect of dopamine without pretreatment 
η 0—16 min 15—30 min 30—45 min 45—60 min 60—120 min 
17 1751 28 64 ι 14 21 ι 6 21 ι 10 6 2 1 13 
17 782 1 9 6 + + + 959 l U e * * * 413 ι Юб** 361 12 69 t 11 
17 3 8 3 i 9 2 * · · 2361 6 1 · · · 110 ι 4 1 · · 19 ι 4 3 2 1 7 
17 628 1 1 5 2 6 2 6 t l 8 3 315 ι 104 68 ι 13 69 ι 12 
Drug 
Salme 
Dopamine 
Haloperidol + 
Dopamine 
Clozapine + 
Dopamme 
Dose 
(Mg) 
— 
10 
10 
10 
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tion of doses of 1, 5, and 10 pg. When com-
pared to the mean activity during the first hour 
following salme injection, m 10 of 18 animals 
the level of activity after 1 ßg of apomorphme 
was m the range between the mean level plus or 
minus twice the standard deviation (334 ± 239 
interruptions). In 6 animals a higher value was 
found and m 2 animals a lower. After a dose of 
5 μζ of apomorphme 9 animals showed a higher 
activity and 2 a lower, whereas after 10/Ug(1.0 
μΐ) of apomorphme the activity was stronger m 
3 animals and less m 6 animals When loco­
motor stimulation was found, this was general­
ly of the same type as after dopamine and 
lasted for about half an hour Little difference 
was seen between the effects of low and high 
doses Both stimulation and depression of ac­
tivity were sometimes observed in the same 
animal with different doses of apomorphme. 
Bilateral administration of the compound 
ET 495 did not produce a clear locomotor 
stimulation Although there was a tendency to 
somewhat higher activity from 15 mm after the 
injection of 1 Mg, this was less pronounced or 
absent after injection of higher doses 
Also no clear stimulation was found follow­
ing injection of a- or ^-adrenergic agonists 
(table 6). Clonidine produced an initial depres­
sion of activity, which was most pronounced 
after a dose of 10 μg, while in the second hour 
following the injection a slight enhancement of 
activity was seen A depression of activity was 
also observed after administration of phenyl­
ephrine, especially after a dose of 10 jug. No 
consistent effects were observed following in­
jection of the ^ -adrenergic agonist isoprenalme. 
In a few animals the cholinergic agonist 
carbachol was applied bilaterally. These ani­
mals showed a strong locomotor stimulation 
upon injection of a dose of 0 2 /ig, which lasted 
for about 15—30 mm Higher doses of 0.5 and 1 
μg also produced a strong locomotor stimula­
tion, which was, however, accompanied by 
severe clonic-tomc convulsions. These convul­
sions were never seen following injection of 
dopamine or the other stimulants. 
3 16 Injection of theophylline 
The phosphodiesterase-inhibitor theophyl­
line, administered m a dose of 10 Mg bilaterally 
into the nucleus accumbens, also produced a 
clear locomotor stimulation, which started 
within 5 mm after injection and lasted for 
about 30 mm (table 7) Pretreatment with 
halopendol in a dose of 0 2 mg/kg ι ρ 10 min 
before the intracerebral injection resulted m a 
reduction of the effect of theophylline. The 
locomotor stimulation mduced by theophyl­
line was not diminished by pretreatment with 
clozapine in a dose of 2 mg/kg ι p. 10 mm 
TABLE 6 
The effect of injections of Clonidine, phenylephrine and isoprenalme bilaterally into the nucleus accumbens 
upon locomotor activity Mean numbers of interruptions ±S Ε M are given η • number of rats Levels of 
significance * p < 0 0 5 , * * p < 0 0 1 , * * * p < 0 001 with respect to saline 
Drug 
Saline 
Gonidi ne 
Phenylephrine 
Isoprenalme 
Dose 
(μ«) 
-
1 
10 
1 
10 
1 
10 
η 
9 
9 
9 
9 
9 
9 
9 
0—15 min 
1 6 2 ι 17 
105± 12 · 
76 ι 15 · 
152 ι 27 
131 i 28 
179 t 37 
1 5 2 i 17 
15—30 min 
5 9 i 15 
3 8 i β 
40 ± 10 
3 6 ι 13 
23 ι 16 
34 ι 7 
90 ι 20 
30—45 min 
381 4 
53 t 13 
37 1 7 
1 2 ι 6 · · 
3 ι 1»** 
11 ι 5** 
5 6 ι 17 
45—60 min 
6 1 * 20 
53+ 15 
4 9 * 12 
3 0 * 11 
4 ι 3* 
2 9 * 13 
4 5 ι 10 
60—120 mm 
89 ι 19 
1 1 4 ι 33 
1 4 5 ι 13 · 
27 ι 6 · 
48 ι 23 
4 6 ι 12 
8 7 ι 26 
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TABLE 7 
The effect of injection of theophylline bilaterally into the nucleus accumbeiu upon locomotor activity and the 
influence of pretreatment with Haloperidol and clozapine on thu effect Mean numbers of interruption« IS Ε M 
are given η - number of rats Haloperidol (0 2 mg/kg ι ρ ) and clozapine (2 mg/kg ι ρ ) were given 10 min before 
the intracerebral injection Levels of Bigmficance * ρ < 0 Об, + + ρ < 0 01 with reapect to saline. * ρ < 0 05 with 
respect to the effect of theophylline without pretreatment 
Drug Dose η 0—15 mm 16—30 mm 30—45 nun 45—60 nun 60—120 min 
Sahne 
Theophylline 
Haloperidol + 
Theophylline 
Clozapine + 
Theophylline 
— 
1 0 
1 0 
1 0 
9 174 ι 23 23 i 4 
9 612 ι 102** 341 * 101 + 
9 313 * 6 3 · 107 i 24* 
9 686 ι 97 568 ι 133 
17± 6 
17 t β 
25 i 7 
100 i 36* 
13 t 7 
101 5 
9 i 3 
2 5 i 11 
61 i 18 
3 6 i 20 
18 ± 8 
47 i 14 
TABLE 8 
The effect of injections of dopamine and other compounds bilaterally into the tuberculum olfactonum upon 
locomotor activity Mean numbers of interruptions ±S Ε M are given π B number of rats Levels of significance 
* ρ < 0 06, * · ρ < 0 01, · * * ρ < 0 001 with respect to saline 
Drug Dose 
№g) 
0—15 min 15—30 min 30—45 mm 46—60 mm 60—120 mm 
Saline 
Dopamine 
Noradrenaline 
Serotonin 
d Amphetamine 
Apomorphine 
(10μ1) 
ET 495 
-
1 
5 
1 0 
1 
5 
1 0 
1 
5 
1 0 
1 
5 
1 0 
1 
5 
1 0 
1 
5 
10 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
9 
196 ± 
3 8 9 i 
6 4 6 i 
821 * 
132 1 
193 t 
179 ± 
1 2 6 i 
H O i 
228 + 
697 1 
9 9 5 i 
1082 1 
457 1 
4 6 2 i 
579 1 
105 ± 
70 ι 
4 4 i 
1 3 
5 3 · · 
5 9 · * * 
1 0 7 · · · 
1 7 · 
47 
4 6 
2 3 · 
17** 
5 2 
8 7 · * 
5 7 · * * 
100**· 
7 8 · * 
8 4 · 
7 3 · * · 
1 6 · · 
1 0 · · · 7».* 
4 7 i 
7 7 i 
313 1 
6 7 5 i 
29 ι 
2 9 i 
5 1 1 
Ι β ι 
9 i 
2 6 i 
3 5 6 i 
7 4 6 i 
8 8 0 i 
2 2 8 i 
2 7 4 i 
4361 
1 6 i 
3 i 
2 i 
8 
27 
6 8 · · 
1 0 4 · · · 
17 
7 * 
2 3 
7 * 
3 · · » 
4 * 
7 6 · * 
6 6 * · * 
130·** 
6 2 * 
7 3 * 
108»· 
1 0 · 
1 · · * 
1 · · · 
20 ι 
1 4 i 
4 2 * 
1 2 3 i 
3 i 
10 ι 
8 i 
1 2 i 
1 4 i 
1 8 i 
1261 
323 1 
3 6 6 i 
53 ι 
7 7 i 
1 6 5 i 
4 i 
6 ± 
2 i 
4 
7 
9 * 
28*· 
1 * · · 
4 
2 » · 
6 
8 
9 
3 7 * 
2 4 · · * 
9 3 · · 
9 · · 
2 3 · 
4 8 · · 
1 · · 
3 · · 
1 · · 
H i 
10 ι 
1 8 i 
1 1 1 
3 i 
8 i 
1 1 1 
1 2 i 
15 1 
9 i 
4 9 i 
91 ι 
7 8 1 
1 7 i 
3 1 1 
4 6 i 
3 1 
4 i 
5 i 
3 
3 
9 
5 
1 · 
2 
5 
7 
β 
4 
19 
1 1 · · · 
1 7 · · 
6 
12 
1 0 · 
2 · 
1 
4 
60 ι 15 
41 ι 13 
3 2 ι 8 
22 ι 4 
18 ι 5 · 
1 6 ι 5 · 
3 2 ι 11 
36 ι 10 
23 ι 10 
3 7 ι 17 
6 7 ι 24 
7 6 ι 18 
9 2 ι 29 
50 t 13 
51 ι 21 
68 ι 27 
29 ι 10 
33 ι 9 
3 1 1 6 
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before the intracerebral injection, but seemed 
even somewhat more pronounced. 
3.2. Injections into the tuberculum olfacto-
rium 
3.2.1. Injection of monoamines 
The effects of injections of monoamines in 
the tuberculum olfactorium are shown in table 
8. Dopamine induced a clear stimulation of 
locomotor activity, which was already seen at a 
dose of 1 μg. With doses of 5 and 10 μg the 
effect was stronger and lasted for about 30—45 
min, the pattern of activity being the same as 
that following injection into the nucleus ac-
cumbens. Also the appearance of the animals 
was the same as in the nucleus accumbens 
group. Noradrenaline and serotonin did not 
stimulate locomotor activity. Instead a tenden­
cy to depression of activity was seen, although 
this wa~ not clearly dose-dependent. 
3.2.2. Injection of dopaminergic stimulants 
As in the nucleus accumbens experiments, 
the strongest effect was seen following injec­
tion of amphetamine (table 8). A dose of 1 Mg 
already produced enhanced activity lasting for 
about 45 min. A dose of 5 μg was nearly as 
effective as 10 Mg. 
The effect of apomorphine was less intense 
and also somewhat shorter lasting. The differ­
ence in the effects of low (1 Mg) and high (10 
Mg) doses was relatively small. In contrast to the 
injections into the nucleus accumbens, the 
results of apomorphine injections into the 
tuberculum olfactorium were less equivocal, 
nearly all animals showing increased locomotor 
activity at all doses tested. 
No locomotor stimulation was seen follow­
ing injection of the compound ET 495. Instead 
a depression of activity was observed, which 
was most pronounced with the higher doses. 
лМЭО/и 
A9410^ 
Αββ20μ 
АвЗвО^ 
Fig. 2. Frontal lections through the rat brain according to the atlas of König and Klippel (1Θ63), indicating the 
site· where injections intended for the nucleus accumbens (left side) and the tuberculum olfactorium (right side) 
wen given. The numbers within circles refer to the different rats. For the sake of clearness only a limited number 
of placements in the nucleus accumbens are shown. 
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3 3 Histological examination 
In fig. 2 the sites are shown where injections, 
intended for the nucleus accumbens and the 
tuberculum olfactonum, were given. For the 
nucleus accumbens, only a limited number of 
placements are depicted for the sake of clear­
ness. In the remaining rats a similar location 
was found. Besides an accumulation of ink on 
the injection site, a spreading over a distance of 
about 2—3 mm in and along the cannula-track 
was often noted, which might have been caused 
in part by suction at removal of the cannula. 
Some ink was seen in the lateral parts of the 
nucleus accumbens at the most medial injec­
tion sites m the tuberculum olfactonum. 
4. Discussion 
The present study shows that bilateral injec­
tion of relatively low doses of dopamine into 
the nucleus accumbens of freely moving non-
pretreated rats results in stimulation of loco­
motor activity In contrast with this it was 
found by others that bilateral administration of 
dopamine in doses up to 100 μg into the 
neostriatum of non-pretreated rats did not 
result in hyperactivity (Costali et al, 1974b) or 
stereotyped behaviour (Costali and Naylor, 
1974a). Activation of the dopaminergic system 
m the nucleus accumbens seems therefore to 
result in overt behavioural changes more easily 
than activation of the neostnatal dopaminergic 
system. 
Earlier, we had found that injection of dop­
amine into the nucleus accumbens of rats 
which were pretreated with the monoamine 
oxidase-inhibitor nialamide, produced a strong 
and long-lasting locomotor stimulation (Pijnen­
burg and Van Rossum, 1973,Pijnenburgetal, 
1975b). It must be mentioned that there are 
several differences between non-pretreated and 
malaimde-pretreated animals in this respect. 
First of all with nialamide-pretreatment a loco­
motor stimulation of much longer duration was 
found than in the present study, as could be 
expected when the breakdown of dopamine is 
retarded. Furthermore, whereas the effect of 
dopamine in non-pretreated rats appeared 
within a few minutes after injection, a longer 
time of latency, sometimes of more than one 
hour, was often found after nialamide-pre­
treatment; this lag was followed by a rather 
sudden increase of locomotor activity During 
the period of latency, signs of depression, 
involuntary movements, abortive grooming 
and scratching of the body were observed. 
Since nialamide not only influences the metab­
olism of dopamine (Lisch et al., 1968) but also 
of other monoamines, especially serotonin 
(Rowe et al., 1959, Fune, 1965), it might be 
possible that changes in these other mono­
amine systems interfere m some way with the 
effect of dopamine. A further difference be­
tween non-pretreated and malaimde-pretreated 
rats is found m the effects of injection of 
noradrenaline. In malamide-pretreated rats 
noradrenaline produced locomotor stimulation 
of the same type as did dopamine but less 
intense, which could be inhibited by local 
administration of the dopamine antagonist 
halopendol, but not by noradrenaline antago­
nists (Pijnenburg et al, 1975b). In the present 
study, however, it was found that noradrena­
line, and also the α-adrenergic agonists cloni-
dine and phenylephrine, did not stimulate loco­
motor activity following injection into the 
nucleus accumbens but rather produced a de­
pression of activity. A similar result was found 
following injection of serotonin. It might be 
conceivable that exogenously applied nor­
adrenaline, apart from an influence upon nor­
adrenergic systems, also displaces dopamine 
from its binding sites Dopamine would only be 
accumulated and released m amounts sufficient 
to result m locomotor stimulation after mono­
amine oxidase-inhibition. 
It is reasonable to assume that the locomotor 
stimulation following injection of dopamine is 
brought about by dopamine itself and not by 
its metabolites, since of the metabolites tested 
only DOP AC produced a slight initial increase 
of activity, which was, however, far less than 
the effect of dopamine. It could also be ex­
cluded that changes in pH or osmolality were 
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responsible for the locomotor stimulation, 
since variation of these parameters alone did 
not produce enhanced activity. Also the effect 
of dopamine was not influenced by media with 
different osmolality or pH, except when apH 8 
medium was used, which may be due to insta-
bility of dopamine m an alkaline environment 
Although carbachol also produced a strong 
stimulation of locomotor activity, it is unlikely 
that the effects of dopamine are mediated by 
stimulation of cholinergic mechanisms, since 
after administration of dopamine no convul-
sions were seen as after carbachol. 
d-Amphetamine, whose main action is sup-
posed to be indirect through release and/or 
inhibition of uptake of endogenous catechol-
amines (Fuxe and Ungerstedt, 1970), was clear-
ly more effective than dopamine (also when 
compared on a molar basis) This may indicate 
that dopamine is less effective when it must 
reach synapses from an exogenous source than 
when it is released from its presynaptic stores 
directly into a synapse. Apomorphine, which is 
assumed to act directly on dopamine receptors 
(Andén et al., 1967, Ernst, 1967, Roos, 1969), 
produced inconsistent effects following injec-
tion into the nucleus accumbens. Besides stim-
ulation, a depression of locomotor activity was 
also seen, which was somewhat more promi-
nent at the highest dose. This difference m 
effects cannot be ascribed m a simple way to a 
difference m injection sites, smce opposite 
effects were sometimes observed m the same 
animal with different doses. Moreover, am-
phetamine and dopamine, injected at the same 
sites, produced only locomotor stimulation 
(see also fig. 1). It might be possible that the 
effect of apomorphine on postsynaptic struc-
tures is complicated by an effect of this drug on 
presynaptic dopamine receptors, resulting m a 
diminished release of endogenous dopamme 
(Famebo and Hamberger, 1971, Langer, 
1974). It could also be considered m how far 
two different types of dopamme receptors 
(Cools and Van Rossura, 1975) play a role m 
this effect of apomorphine. It is interesting to 
mention that both stimulant and depressant 
effects of apomorphine were also found upon 
self-stimulation with electrodes placed aimong 
other sites m the nucleus accumbens (Broek-
kamp and Van Rossum, 1974) 
ET 495, which has been reported to mduce 
biochemical and behavioural effects com-
parable to those of apomorphine (Corrodi et 
al., 1972) did not produce a clear locomotor 
stimulation following injection into the nu-
cleus accumbens. Other studies in agreement 
with this finding (Costali and Naylor, 1974a, 
Miller and Iversen, 1974) suggested that not ET 
495 itself but its metabolite S 584 may repre-
sent the active component mediating the dop-
amme stimulant properties of ET 495 
The effect of dopamme could be antago-
nized by pretreatment with halopendol, which 
is considered as a rather specific dopamme 
antagonist, especially when used m low doses 
(Van Rossum, 1966, Anden et al., 1970). 
Although an action of halopendol outside the 
nucleus accumbens remains possible, we had 
previously found m malamide-pretzeated rats 
that local injections of halopendol also inhib-
ited the locomotor stimulant effect of dop-
amme. A slight, but not significant reduction of 
locomotor stimulation was found following 
pretreatment with clozapme. Clozapine is an 
antipsychotic agent which, m contrast to clas-
sical antipsychotic agents, exhibits only very 
weak cataleptic and antistereotypic activities 
(Stúle et al., 1971, Costali and Naylor, 1973). 
Andén and Stock (1973) reported that cloza-
pme produced a greater increase of HVA m the 
limbic system of the rabbit than m the stria-
tum. This result was, however, not confirmed 
by Wiesel and Sedvall (1975), who found in the 
rat a stronger HVA rise m the neostriatum than 
m the tuberculum olfactonum following cloza-
pme. Whether a possible inhibiting effect of 
clozapine m the present experiments is masked 
by its anticholinergic properties (Miller and 
Sahakian, 1974) remarne to be shown. It might 
be possible that higher doses of clozapme 
would have been more effective, but it is 
known that clozapine also produces relaxation 
of skeletal muscles (Stille et al, 1971), which 
may interfere with enhanced locomotor activ-
ity 
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The phosphodiesterase inhibitor, theophyl-
line, also produced clear locomotor stimulation 
following injection into the nucleus accum-
bens. Horn et al (1974) found that there exists 
a dopamine-sensitive adenylate cyclase in the 
nucleus accumbens It might be possible, there-
fore, that the effect of dopamine is brought 
about by activation of adenylate cyclase, re-
sulting in enhanced formation of cyclic AMP A 
nse in cyclic AMP as a result of inhibition of 
phosphodiesterase might then be responsible 
for the effect of theophylline. 
Injections into the tuberculum olfactonum 
had, in general, the same effects as injections 
mto the nucleus accumbens It must be born in 
mind, however, that the tuberculum olfacto-
num by virtue of its flat elongated shape is 
much more difficult of access for local injec-
tions than is the nucleus accumbens. With the 
present technique it is impossible to selectively 
reach the greater part of this structure. The fact 
that the tuberculum olfactonum is situated 
immediately below the nucleus accumbens is a 
particular difficulty m this respect. Although it 
cannot be completely excluded that the nu-
cleus accumbens was involved in the effects of 
injections into the tuberculum olfactonum, the 
fact that, a) no differences in latency were 
found between injections of dopamine into 
these two structures, b) injections into more 
lateral regions of the tuberculum olfactonum 
were as effective as injections in the neigh-
bourhood of the nucleus accumbens, may sug-
gest that activation of the dopaminergic system 
in the tuberculum olfactonum, at least in the 
region where injections were given, also can 
result m locomotor stimulation. As in the 
nucleus accumbens the effect of injections of 
amphetamine mto the tuberculum olfactonum 
was stronger than that of dopamme. However, 
no depressant effects of apomorphine were 
seen in contrast to injections into the nucleus 
accumbens, whereas locomotor activity was 
reduced after ET 495. What may be the cause 
of these different reactions following injection 
mto the tuberculum olfactonum and into the 
nucleus accumbens remains to be elucidated. 
In conclusion, the present study indicates 
that activation of dopaminergic structures m 
the nucleus accumbens and probably also m the 
tuberculum olfactonum, both terminal areas of 
the mesohmbic dopamme system, can result in 
locomotor stimulation. 
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Abstract The effect of intracerebral administration of antag-
onists of dopamine and noradrenaline upon the locomotor 
stimulation induced by intraperitoneal injection of (/-am-
phetamine sulfate in rats was investigated Injection of low 
doses of the dopamine antagonist haiopendol (2 S μg and 
5 μg) bilaterally into the nucleus accumbens antagonized 
the locomotor stimulation following ¿-amphetamine No 
significant inhibition was observed following administration 
of the alpha-adrenergic antagonist phentolamine or the 
Introduction 
Pharmacological and biochemical studies have shown 
that brain catecholamines are involved in the central 
stimulant actions of amphetamine (Fuxe and Unger-
stedt, 1970, Glowinski, 1970) At the moment there 
is still some controversy regarding the individual role 
of dopamine and noradrenaline 
The actions of ¿-amphetamine can be inhibited 
by the tyrosine hydroxylase inhibitor a-methyl-/?-
tyrosine, which inhibits the synthesis of both dopamine 
and noradrenaline (Weissman and Кое, 1965, Weiss-
man et al, 1966, Randrup and Munkvad, 1966, 
Domimcand Moore, 1969, Scheel-Kruger, 1971) In­
hibition of the synthesis of noradrenaline but not of 
dopamine by diethyldithiocarbamate or disulfiram re­
duces the locomotor stimulant effect of ¿-amphet-
amine, but does not antagonize the stereotyped behav-
iour (Randrup and Scheel-Kruger, 1966, Pfeifer et 
al, 1966, Maj and Przegalinski, 1967) From these 
studies it was concluded that the locomotor stimulant 
effect of amphetamine is mediated by noradrenaline, 
while the stereotyped behaviour after amphetamine 
is mediated by dopamine Carlsson ( 1970), however, 
beta-adrenergic antagonist propranolol into the nucleus ac-
cumbens Injection of the same doses of haiopendol into 
the caudate nucleus did not inhibit the ¿-amphetamine in-
duced locomotor achvity, in contrast to the effects seen fol-
lowing injection into the nucleus accumbens 
The results confirm the significance of dopaminergic 
mechanisms for the locomotor stimulant effect of ¿-am-
phetamine and indicate that the mesohmbic dopamine sys-
tem plays an important role in this respect 
suggested that diethyldithiocarbamate has a central 
depressant action with rapid onset which may not be 
related to noradrenaline depletion Experiments with 
more specific dopamine-/3-hydroxylase inhibitors like 
U-14,624 or FLA-63 in rats and mice did not or only 
moderately reduce the locomotor stimulation follow-
ing amphetamine (Johnson et al, 1970, Svensson, 
1970, Thornburg and Moore, 1973b, Hollister et al, 
1974) 
The relative effect of d- and /-amphetamine on 
the accumulation of exogenous dopamine and nor-
adrenaline in different brain regions and on behaviour 
led Taylor and Snyder (1971) to suggest that nor-
adrenaline is selectively involved in amphetamine-in-
duced locomotor stimulation, whereas the compulsive 
gnawing syndrome is mediated by dopamine The 
relative potencies of ¿- and /-amphetamine on cate-
cholamine uptake and on motor activity, reported in 
their study, however, are not consistent with those re-
ported in other biochemical and behavioural studies 
(Ferns et al, 1972, Scheel-Kruger, 1972, Svensson, 
1971, Harns and Baldessanm, 1973, Chiueh and 
Moore, 1974, Thornburg and Moore, 1973a) Costa 
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et al (1972) found that a dose of tf-amphetamine 
which enhanced motor activity in rats increased the 
turnover of brain dopamine but not of brain nor-
adrenaline 
Furthermore, it was shown that dopamine antag-
onists were more potent in blocking amphetamine-
induced locomotor activity in rats and mice than nor-
adrenaline antagomsts (Rohnski and Scheel-Kruger, 
1973) Other studies also suggest that dopamine is 
not only involved in stereotyped behaviour but plays 
an important role in locomotor activity as well (Carls-
son, 1970, Creese and Iversen, 1973, Fibiger et al, 
1973, van Rossum, 1970) 
Until now much less attention has been paid to 
the different dopaminergic systems in the brain with 
regard to the action of amphetamine In the present 
work, the respective role of the nigro-neostnatal 
dopamine system and the mesolimbic dopamine sys-
tem with cell bodies in the A-10 group (classification 
according to Dahlstrom and Fuxe, 1965) and nerve 
terminals mainly in the nucleus accumbens and tu-
berculum olf actonum (Anden et al ,1966, Arbuthnott 
et al, 1970,Ungerstedt, 1971) have been studied with 
respect to the locomotor stimulant action of ¿-am-
phetamine by means of intracerebral injections of the 
dopamine antagonist halopendol 
Methods 
Surgery 
Male Wrstar rats were used, weighing 200 ± 20g at the time 
of operation Under sodium pentobarbital anesthesia 
(40mg/kg ι ρ ) double barrelled stainless steel cannulae 
were stereotaxically implanted into the caudate nucleus 
(caudale-putamen complex) and into the nucleus accum­
bens The injection sites chosen had the following coordi 
nates, according to the alias of Komg and Klippel (1963) 
caudate nucleus A8 0,L2S,H05 and nucleus accumbens 
A94,L1 2 , H - 0 6 Preliminary expenments had revealed 
that slight modifications of these coordinates were necessary 
to reach the intended injection sites, probably because these 
rats were larger than those used in the atlas The cannulae 
placed in the nucleus accumbens were brought in from the 
lateral side at an angle of 10° with the midline in order 
to avoid the ventricular system The cannulae, which had 
an outer and inner diameter of 0 63 mm and 0 30 mm re­
spectively were fixed on to the skull with acrylic dental ce­
ment (Paladur) Following surgery the animals received 
Oxytetracycline (Terramycine) m their drinking water for 
a penod of S days 
The rats were housed in individual cages with free access 
to food and water Illumination was present from 6 00 a m 
to 6 00 ρ m The expenments were started after a period 
of 10 days, during which time the rats were accustomed 
to handling and to the injection procedure and during which 
tune they were adapted to the achvity cages 
Apparatus 
Locomotor activity was measured in activity cages equipped 
with 3 light sources and opposite to them 3 photoelectric 
cells 2 cm above a gnd floor The dimensions of the cages 
were 36 cm X 24 cm X 25 cm The cages were situated 
in a ventilated soundproof box The interruptions of the 
light beams were registered on a cumulative Ralph-Ger-
brands recorder 
Procedure 
All expenments were started at the same time of the day 
(9 00 a m ) After an adaptation penod of 1 hr for each 
experiment in the activity cages locomotor activity was mea­
sured during 3 hrs (6 penods of 30 mm) following the in­
jection of d-amphetamme d-Amphetamine was injected 
mtrapentoneally The standard dose of 1 0 mg/kg was cho­
sen because this dose reliably induces stimulation of 
locomotor activity without stereotyped gnawing or licking 
behaviour 
Intracerebral injecnons of different drugs were given 
bilaterally by means of a 5 μΐ Hamilton syringe with a 
31 gauge needle, which extended into the brain tissue 
1 0-1 5 mm below the tip of the permanently implanted 
cannula Injections into the brain were given immediately 
before the injection of d-amphetaminc and in the case of 
halopendol 15 mm earlier too The injection volume was 
0 5 or 1 0 μΙ on each side Treatments were given in a rando­
mized sequence At least two days of rest were given be­
tween the different treatments 
Drugs 
The following drugs were used ¿-amphetamine sulfate, 
halopendol (Serenase), phentolamine methanesulfonate 
(Regnine), /-propranolol All drugs, except the commer-
cial preparations, were dissolved in a 0 9% saline solution 
Saline was used as a control 
Statistics 
Statistical companson between different treatments was 
made using Students r-test Two tailed probability values 
are reported 
Histology 
At the end of the expenments 1 0 μΐ of an ink solution was 
injected to verify the site of injection The rats were perfused 
with saline and a 10% formalin solution through the left 
cardiac ventnele under sodium pentobarbital anesthesia 
The brains were removed and kept in a 4 % formalin solution 
for at least 7 days and were then sectioned for control of 
the site of injection Animals in which the injection sites 
were incorrect were discarded from the results 
Results 
The Effect of Injections into the Nucleus Accumbens 
upon ¿-Amphetamine Sulfate-Induced 
Locomotor Activity 
Intraperitoneal injection of ¿-amphetamine sulfate 
( 1 mg/kg) caused a significant enhancement of loco-
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Fig. 1. Locomotor activity of rats dunng six successive 30-min periods following drug administration Mean values ± S.E.M. 
are given, η = number of expenments 
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Fig. 2. Locomotor activity of rats dunng six successive 30-min periods following injections into the nucleus accu m bens imme­
diately before d-amphetamine sulfate 1 mg/kg ι p. Mean values ± S.E.M. are given л = number of expenments 
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motor activity during the first four 30-min periods 
compared to the intraperitoneal injection of saline in 
the same volume of 1 ml/kg (Fig. 1). During the first 
30-min period after saline injection locomotor activity 
was stronger than during the following period; be­
cause the animals showed exploratory behaviour fol­
lowing the manipulation and replacement in the cage. 
The effect of d-amphetamine was diminished during 
all periods when saline was injected into the nucleus 
accumbens, immediately before the injection of ¿-am-
phetamine (Fig. 1). The differences, however, were 
not significant, although in the third 30-min period 
there was a considerable diminishment of activity 
(P<0.10). It is possible that the intracerebral in-
jection disturbs the integrity of the nucleus in such 
a way that it influences the effect of J-amphetamine. 
Since in preliminary experiments it was found that the 
solvent of the commercial preparations used in this 
study also produced a reduction of activity comparable 
with saline, the effect of intracerebral injections of 
other substances was compared with the effect of sa-
line. Injection of the alpha-adrenergic antagonist 
phentolamine (10 μg bilaterally) did not significantly 
change the effect of ¿-amphetamine as compared to 
the injection of saline during any period (Fig. 2). The 
beta-adrenergic antagonist propranolol (5 μ§ bilat­
erally) also had no clearcul influence (Fig 2). 
In contrast to these noradrenergic antagonists, in­
jection of the dopamine antagonist halopendol in 
doses of 2.3 and 5 μg bilaterally given both imme­
diately (Fig. 3) and 15 min before (not shown) in­
jection of ¿-amphetamine resulted in an inhibition of 
the ¿-amphetamine-induced locomotor activity. This 
inhibition was significant during the first, second and 
fourth 30-min period for both doses of halopendol. 
During the third period the inhibition was only 
significant for the 5 μ§ dose of halopendol 
The Effect of Injections into the Caudate Nucleus 
upon ¿-Amphetamine Sulfate-Induced Locomotor 
Activity 
In animals with cannulae in the caudale nucleus in-
traperitoneal injection of ¿-amphetamine sulfate 
( 1 mg/kg) resulted in a stimulation of locomotor activ-
ity which was significant during the first five 30-min 
penods compared to intraperitoneal saline injection 
(Fig. 4). Injection of saline bilaterally into the caudate 
nucleus resulted, just as in the nucleus accumbens ex-
periments, in a non-significant reduction of the effect 
of ¿-amphetamine (Fig. 4) 
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Fig 4 Locomotor activity of rats during six successive ЗО-тт periods following drug administration Mean values ± S Ε M 
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Administration of the alpha-adrenergic antagonist 
phentolamine (10 μg bilaterally) had no significant in­
fluence as compared to the intracaudate saline in­
jection (Fig S) In contrast to the effects seen in the 
nucleus accumbens group, injection of halopendol in 
doses of 2 S and S μg bilaterally into the caudate nu­
cleus both immediately before (Fig 6) and IS mm be­
fore (not shown) the ¿-amphetamine administration 
did not result in a significant lowering of the d-am-
phetamine effect during any of the 30-mm penods 
Due to the fact that two animals showed a rather high 
activity following injection of the 5 μg dose of halo­
pendol immediately before the ¿-amphetamine in-
jection a stronger locomotor activity was found in this 
expenmenl (Fig 6) 
Discussion 
The present study shows that injections of halo-
pendol bilaterally into the nucleus accumbens 
strongly antagonize the stimulation of locomotor ac-
tivity following intraperitoneal injection of ¿-am-
phetamine Halopendol is considered as a relatively 
specific dopamine antagonist (Andén et al, 1970a, 
Janssen et al, 1965, van Rossum, 1966) This result 
therefore suggests an important role for the meso-
limbic dopamine system in ¿-amphetamine-induced 
locomotor stimulation, although in the present 
study only the nucleus accumbens was investi-
gated because in the rat this nucleus is better suited 
for the intracerebral injection technique than the other 
terminal areas of the mesohmbic dopamine system 
The doses used in this study (2 5 and 5 μg bilaterally) 
for inhibition of the locomotor stimulant action of ¿-
amphetamine are relatively low when compared to the 
doses, administered into the caudate nucleus or globus 
pallidas (20-100 μgbilaterally) which seem necessary 
to antagonize the stereotyped behaviour induced by 
amphetamine (Fog etal, 1971, Costali etal, 1972) 
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Injection of the alpha-adrenergic antagonist 
phentolamine and the beta-adrenergic antagonist 
propranolol into the nucleus accumbens did not result 
in a significant inhibition of the d-amphetamine effect. 
Although the main catecholamine in the nucleus ac­
cumbens is dopamine (Andén eia/., 1966; Ungerstedt, 
1971; Lidbrink et ai, 1974), the occurrence of nor-
adrenaline in this nucleus is also described (Jacobowitz, 
1973; Koob etal., 1974). The noradrenergic system 
in this nucleus is probably not of major importance 
for stimulation of locomotor activity by ¿/-amphet-
amine This system, however, forms only a small part 
of the noradrenergic systems in the brain and therefore 
the role of noradrenaline cannot be excluded. Several 
authors assume that both dopamine and noradrenaline 
are involved in the regulation of locomotor activity, 
but that dopamine is of primary significance. As al-
ready mentioned in the introduction, Rohnski el al. 
(1973) found that low doses of neuroleptic agents 
completely blocked rf-amphetamine-induced locomo-
tor activity, whereas noradrenaline antagonists pro-
duced only partial inhibition. Furthermore, stim-
ulation of dopamine receptors by apomorphine 
enhances locomotor activity, whereas activation of 
central noradrenaline receptors by Clonidine is in-
effective in this respect Combined stimulation of both 
dopamine and noradrenaline receptors, however, re-
sults in a marked potentiation of the effect of apomor-
phine alone (Andén et al., 1970b; Maj et al., 1972; 
Andén etat., 1973). 
In contrast to the effects in the nucleus accumbens, 
injection of haloperidol into the caudate nucleus did 
not inhibit the d-amphetamine-induced locomotor ac-
tivity. It is possible that the injection-volume or doses 
used are too small to reach the whole nucleus and 
that there remain enough free dopamine receptors 
However, Creese and Iversen ( 1972) found that bilat-
eral lesions of the substantia nigra with 6-hydroxy-
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dopamine did not reduce locomotor activity following 
amphetamine, whereas stereotyped behaviour was 
abolished In contrast, Fibiger et al (1973) reported 
that amphetamine-induced locomotor stimulation was 
significantly reduced following bilateral injection of 
6-hydroxydopamine into the substantia nigra, but not 
completely abolished as following intraventricular in­
jection of 6-hydroxydopamine in tranylcypromine 
pretreated rats The role of the nigro-neostnatal 
dopamine system can therefore not be excluded with 
certainty 
Several data suggest that the mesohmbic dopa­
mine system may play a role in states of hyperactivity 
Electrical stimulation of the A-10 group in rats causes 
a syndrome of hyperactivity charactenzed by con­
tinuous exploration and sniffing (Miliaressis, 1973, 
Broekkamp, personal communication) Injection of 
ergometnne bilaterally into the nucleus accumbens 
(Pijnenburg et al, 1973) and injection of dopamine 
in nialamide pretreated rats (Pijnenburg and van Ros-
sum, 1973) results in a strong and long lasting stim­
ulation of locomotor activity in contrast to injection 
of these substances into the caudate nucleus In non-
pretreated rats injection of ¿-amphetamine and also 
of dopamine into the nucleus accumbens causes a 
strong but shorter lasting enhancement of locomotor 
activity, whereas noradrenaline causes a depression 
(Pijnenburg, in preparation) It was found that bilat-
eral lesions of the nucleus accumbens and antero-
medioventral region of the caudate nucleus in cats 
prevented the increased locomotor activity induced 
by L-Dopa (Hank and Moms, 1973) 
The fact that injection of halopendol into the nu-
cleus accumbens antagonizes the locomotor activity 
induced by amphetamine does not necessarily imply 
that the locomotor stimulant action of amphetamine 
is brought about by release of dopamine or inhibition 
of uptake mechanisms (Horn et al, 1974) ш this nu-
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deus , although it may play a role in its effects. It is 
found for instance that amphetamine can provoke 
stimulation of locomotor activity and elements of ste-
reotyped behaviour in the thalamic rat with extensive 
lesions of the whole forebrain and striatum (Huston 
and Borbély, 1974). It is likely that amphetamine acts 
on different levels of the brain and that the resultant 
stimulation of activity is not a simple, but a complex 
response, which can be brought about by different 
mechanisms. The inhibition of the locomotor stim-
ulation following ¿-amphetamine by administration of 
haloperidol into the nucleus accumbens can be ex-
plained by assuming that inhibition of the dopaminer-
gic activity in this nucleus results in changes in the 
functional state of this nucleus and other brain struc-
tures, which are in some way involved in the achieve-
ment of the response. Inhibition by haloperidol of the 
effects of amphetamine upon the nucleus accumbens 
itself may play an additional role. 
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Abstract The effects of intracerebral injections of the dopa-
mine-antagonist halopendol upon stereotyped behaviour, 
induced by peripheral administration of apomorphine and 
d amphetamine in rats, were investigated A system was used 
by which injections into the brain could be performed dunng 
the stereotyped behaviour without disturbing the animals 
Administration of low doses of halopendol (2 5 and 5 μg) 
bilaterally either into the caudate nucleus or into the nucleus 
accumbens resulted in a dose-dependent antagonism of stereo­
typed behaviour Whereas the effect of halopendol upon 
stereotyped behaviour, induced by apomorphine, consisted 
Introduction 
Apomorphine and amphetamine are known to pro­
duce stereotyped behaviour in several species In (he 
rat this behaviour consists of increased motor activity, 
followed by continuous sniffing, licking and gnawing 
(Randrup and Munkvad, 1967, Fog, 1969) An inter­
action of these drugs with central dopaminergic 
mechanisms is generally considered to underly this 
behaviour (van Rossum, 1970, Randrup and Munk­
vad, 1970) The syndrome is characteristically pre­
vented by compounds which block dopaminergic 
activity and this inhibition is used as a test in the 
screening of neuroleptic agents (Janssen el al, 1960, 
Janssen et al, 1967) Apomorphine is supposed to act 
directly on dopamine receptors (Anden et al, 1967, 
Ernst, 1967, Roos, 1969), although presynaptic mecha­
nisms of action may be involved (Costali and Naylor, 
1973a) Amphetamine seems to act more indirectly 
by releasing dopamine and/or inhibiting its re-uptake 
(Weissman et al, 1966, Randrup et al, 1966, Fuxe and 
Ungerstedt, 1970) 
The neostriatum, which contains the majority of 
the brain's dopamine (Bertler and Rosengren, 1959, 
Anden et al, 1966) is generally regarded as the most 
important site of action of these drugs Stereotyped 
behaviour has been described following local adminis­
tration into the neostriatum of apomorphine (Ernst 
mainly m a shortening of the duration of action, more abnor­
mal behavioural patterns were seen, when halopendol was 
administered to animals, who had received (/-amphetamine 
No clear differences were found between injections into the 
caudate nucleus and injections into the nucleus accumbens 
Neither administration of the local anesthetic agent pro­
caine into the caudate nucleus nor into the nucleus accumbens 
did significantly reduce apomorphme-mduced stereotyped 
behaviour The possible way in which halopendol, following 
central administration, influences stereotyped behaviour is 
discussed 
and Smehk, 1966), amphetamine (Costali et al, 1972a) 
and dopamine (Fog and Palckenberg, 1971) Very high 
doses, however, were used in these studies and behav­
iour was not always maximally stereotyped 
The results of brain lesion studies are not unequiv­
ocal Amphetamine-induced stereotyped behaviour 
is reported by most authors to be inhibited (Fuxe el al, 
1970, Fog et al, 1970) or reduced (Naylor and Olley, 
1972) by bilateral lesions of the neostriatum, although 
Divac (1972) found no change in the effects of amphet­
amine following large chronic lesions of the corpus 
striatum With regard to the effects of apomorphine 
several authors have found no effect of bilateral lesion 
of the caudate-putamen complex (Divac, 1972, Costali 
et al, 1973b) or even a potentiation (Wolfarth, 1974) 
Furthermore, McKenzie (1972) found that caudate-
putamen lesions were ineffective in abolishing apo-
morphine-stereotypy, whereas lesions of the tuber-
culum olfactonum markedly reduced this behaviour 
In contrast, Fuxe et al (1970) found a complete 
abolishment of apomorphine-induced stereotyped 
behaviour following extensive bilateral electrocoagula­
tion of the neostriatum, while typically a modification 
and partial reduction were found following small 
lesions So it seems that there is some doubt concerning 
the role of the neostriatum in the induction of stereo­
typed behaviour, especially that induced by apomor­
phine 
Key words Halopendol — Apomorphine - ¿-Amphetamine — Procaine — Caudate nucleus — Nucleus accumbens — 
Stereotyped behaviour 
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Dopamine is not only found in the neostnatum, but 
also in other areas of the brain, inter alia the nucleus 
accumbens which forms a part of the meso limbic 
dopamine system (see review by Ungerstedt, 1971) 
In the present study we have investigated the effects 
of local injection of small doses of the dopamine-
antagonist halopendol into the caudate nucleus, and 
into the nucleus accumbens, upon stereotyped behav­
iour induced by peripheral administration of apo-
morphme and amphetamine. 
Methods 
Surgery 
Male Wistar rais were used, weighing 200 + 20 g at the lime 
of operation Under sodium pentobarbital anesthesia 
(40 mg/kg ι ρ ) double-barrelled stainless steel cannulae were 
stereotaxically implanted into the caudate nucleus (caudate-
putamen complex) and into the nucleus accumbens on both 
sides, as previously desenbed (Pijnenburg et ai, 1975) The 
following coordinates were chosen, according to the atlas of 
König and Klippel (1963) caudate nucleus A 7 5, L 2 5, 
Η 0 5 and nucleus accumbens A94, LI 2, H— 06 
Following surgery the animals were housed in individual 
cages with free access to food and water and a penod of at 
least 10 days was given for recovery 
Procedure 
Four groups of rats were used, each consisting of 8 or 9 ani­
mals Two groups had cannulae in the nucleus caudatus and 
the other two groups cannulae in the nucleus accumbens ΟΓ 
the rats with cannulae in the nucleus caudatus, one group was 
used for experiments with apomorphine and the other group 
for expenments with amphetamine The same division was 
made for the animals with cannulae in the nucleus accumbens 
Apomorphine (1 and 2 mg/kg) and ¿-amphetamine sulfate 
(S mg/kg) were administered intra pen toneally Bilateral injec-
tions were given into the brain 15 mm after the administration 
of apomorphine and 20 min after amphetamine In preliminary 
experiments it was found that individual differences in stereo-
typed behaviour exist between different rats, míer alia depen-
dent on the ongoing behaviour (eg rearing or grooming) 
during the onset of stereotypy Therefore intracerebral injec-
tions were given al a time when stereotyped behaviour was 
present and not before In this way changes in behaviour 
could be better observed, especially as an injection-procedure 
was used, which did not disturb the animals At least I week 
of rest was given between the different experiments 
For the intracerebral injections small pieces of a 31-gauge 
needle were used, modified in such a manner that they could 
be fixed in the outer cannula and adjusted at the chosen depth, 
extending into the brain tissue 10—15 mm below the tip of 
the outer cannula These needle-pieces were connected via 
polyethylene tubes with two 5 μΙ Hamilton syringes (one for 
each side of the brain), which were fixed on a device, suspended 
above the cage A swivel system prevented twisting ofthe con 
nection tubes 
Before each experiment, except when apomorphine and 
d-amphetamine were given alone, this system was filled with 
a freshly prepared drug- or control-solution and care was 
made to avoid air-bubbles in the system Following attachment 
to the rat, which was performed under light ether anesthesia, 
Table 1 Scoring system used for the assessment of stereotypcu 
behaviour 
Score Description of behaviour 
0 Absence of stereotyped behaviour 
1 Constant exploratory activity (especially in the 
beginning-phase), periodic mild sniffing or 
chewing movements (especially in the end-phase) 
2 Continuous sniffing with fast repetitive head-
and/or foreleg-movements, frequent locomotor 
activity 
3 Continuous sniffing with fast repetitive hcad-
and/or foreleg-movements, occasionally licking, 
gnawing or biting, short periods of locomotor 
activity 
4 Continuous licking, gnawing or biting with fast 
repetitive head- and/or foreleg-movements, 
remaining at the same place in the cage 
if necessary, half an hour passed before the injection of apo­
morphine or J-amphetamine During this lime the animals 
recovered from the anesthesia, when given, and could adapt 
to the new situation 
Assessment of Stereotyped Behaviour 
Rats were observed in their home cages, 35 κ 25 ж 15 cm, 
which had clear plastic walls, a layer of shavings on the 
bottom and were open on top Stereotyped behaviour was 
scored at 5-min intervals over a period of 60 mm in the case 
of apomorphine and over 150 mm in the case of ¿-amphet-
amine For the assessment of stereotyped behaviour a modi-
fication ofthe scoring system of Costali et al (1972b) with a 
0 — 4 scale was used (Table 1 ) 
Statistics 
Since the stereotyped behaviour consists of several compo-
nents which may be independent of each other, it did not 
appear justified to use arithmetic means Therefore the sign 
test was used to compare scores of the same animals on 
different treatments at each time-interval The Mann-Whitney 
test was used to compare different groups of animals on the 
same treatments Two-tailed probability values are reported 
Drugs 
The following drugs were used apomorphine hydrochloride, 
-^amphetamine sulfate, halopendol (Serenase*) and procaine 
hydrochloride All drugs were dissolved in saline, except the 
commercial preparation Serenase·1 which was given as such 
The doses refer to the salts, except for halopendol 
Histology 
At the end of the experiments the rats were perfused with 
¡»aline and a 10% formalin solution through the left cardiac 
venlnclc under sodium pentobarbital anesthesia The brains 
were removed and kept in a 4 0 0 formalin solution for at least 
7 days and were then sectioned for control of the site of 
injection 
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Results 
Apomorphine-Induced Stereotyped Behaviour 
The effects of intracerebral injections into the caudate 
nucleus and into the nucleus accumbens upon stereo­
typed behaviour, induced by apomorphine in a dose 
of 1 mg/kg i p., are shown in Fig. 1. With apomorphine 
alone the stereotyped behaviour was rapid in onset, 
reached its maximum within 10—15 mm and lasted 
(qr about 45—60 min, after which time the animals 
sat quietly. 
Injection of saline (1.0 μΐ) bilaterally into the 
caudate nucleus or into the nucleus accumbens had no 
significant influence upon the effect of apomorphine 
Administration of Haloperidol in a dose of 2.5 μg 
(0.5 μΙ) bilaterally into the caudate nucleus consider­
ably reduced the stereotyped behaviour, the eflecl 
being significant (P < 0.05) from 25—40 mm, when 
compared to the injection of saline. The same dose of 
haloperidol, injected into the nucleus accumbens, 
also reduced the stereotypy. The difference with injec­
tion of saline was significant (P < 0.05) at 35 and 
40 min. The main effect of the administration of halo­
peridol, either into the caudate nucleus or into the 
nucleus accumbens, was a shortening of the duration 
of the stereotyped behaviour. Within 10—15 mm 
following the intracerebral injection most animals 
slopped the intense head-movements and thereafter 
sat quietly, sometimes immobile, sometimes sporadi­
cally showing mild sniffing or chewing movements 
The effect of injection of haloperidol in a dose of 5 μ§ 
(1.0 μΙ) bilaterally into the caudate nucleus was more 
pronounced than that following a dose of 2.5 μg 
(P <, 0.01 at 25 and 30 mm, Ρ < 0 05 at 35 and 40 mm 
with respect to saline) The same effect was observed 
following administration of the higher dose of halo­
peridol into the nucleus accumbens (P < 0.01 at 25 and 
30 mm, Ρ < 0.05 at 35, 40 and 45 min). Stereotyped 
behaviour ceased in most animals within 5 - 1 0 mm 
following the injection of haloperidol. 
In contrast to haloperidol, the local anesthetic 
agent procaine in a dose of 5 ¿jg ( 1.0 μ|) both following 
injection into the caudate nucleus and following injec­
tion into the nucleus accumbens did not inhibit the 
stereotyped behaviour. Rather a slight enhancement 
was observed, which was, however, not significantly 
different from saline. 
No significant differences were found between the 
caudate nucleus-group and the nucleus accumbens-
group in any of these experiments. 
The effects of intracerebral injections into the 
caudate nucleus and into the nucleus accumbens upon 
stereotyped behaviour, induced by apomorphine in 
a dose of 2 mg/kg ι ρ , are shown in Fig 2. In com­
parison to the dose of 1 mg/kg this dose of apomor-
Couddenucfajs Nudeus асаяпмпз 
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Fig 1 Effect of bilateral injections into the caudate nucleus 
(left side) or into the nucleus accumbens (right side) upon 
stereotyped behaviour, induced by apomorphine 1 mg/kg ι ρ 
Apomorphine was given at time 0, intracerebral injections 
15 mm later (see arrows) Stereotyped activity at 5 mm time-
intervals is expressed as the percentage of animals achieving 
a particular score Open column, score 1, stippled column, 
score 2, hatched column, score 3, black column, score 4. 
A, no intracerebral injection, B, salme (1 0 μΐ), С, halo­
peridol 2 5 μg (0 5 μΙ), D, haloperidol 5 μg (1 0 μΐ), E, pro­
caine 5 Hg (1 0 μΙ) Number of rats 8 
phme produced a more intense stereotyped behaviour 
with a longer duration, lasting for about 1 hr. 
Intracerebral injection of saline (1.0 μΐ), either 
into the caudate nucleus or into the nucleus accum­
bens, did not significantly change the stereotyped 
behaviour. 
Bilateral injection of 2 5 μg (0.5 μΙ) of haloperidol 
into the caudate nucleus resulted m a reduction of 
stereotyped behaviour, which was significant only at 
50 mm after the injection of apomorphine (P < 0.05). 
A stronger inhibition was found following adminis­
tration of 5 μg (1.0 μΙ) of haloperidol, the effect being 
significantly different from saline (P < 0 05) from 25 
to 55 mm. A similar effect was observed when halo­
peridol was injected into the nucleus accumbens. The 
reduction of stereotyped behaviour following a dose 
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Fig. 2. Eflect of bilateral injections into the caudate nucleus 
(left side) or into the nucleus accumbens (right side) upon 
stereotyped behaviour, induced by apomorphine 2 mg/kg ι ρ 
Apomorphine was given at time 0, intracerebral injections 
IS nun later (see arrows). Λ, no intracerebral injection, 
B, saline (1.0 μΙ); С, halopendol 2. S Mg (05μ1), D/halo-
pendol 5 Mg (1.0 μΐ); E, procaine 20 Mg (10μ1) Number 
of rats: 8 For further legends see Fig 1 
of 2.5 Hg bilaterally was significant (P <, 0 05) from 
35 to 60 min, while after 5 Mg of haloperidol the 
difference with saline was significant at the Ρ < 0.01-
level from 30 to 35 mm and at the Ρ ^ 0.05-level from 
40 to 60 min. 
Neither administration of 20 Mg of procaine (1 0μ|) 
into the caudate nucleus nor injection of this dose into 
the nucleus accumbens significantly changed the 
eflect of apomorphine. 
Although the eflect of apomorphine before the 
intracerebral injections sometimes was stronger in the 
caudate nucleus-group than in the nucleus accumbens-
group (P <, 0.05 at 5 and 10 mm in the case of 5 Mg of 
halopendol injection and at 5 mm in the case of 
procaine injection), no significant differences between 
these two groups were observed m the periods follow­
ing intracerebral injections. 
Caudate nucleus tacleus accumbens 
Time [mm) 
Fig 3 Effect of bilateral injections into the caudate nucleus 
(left side) or into the nucleus accumbens (nght side) upon 
stereotyped behaviour, induced by {/-amphetamine 5 mg/kg 
ι ρ ¿/-Amphetamine was given at time 0, intracerebral injec-
tions 20 mm later (see arrows) A, no intracerebral injection, 
B, saline (1 ΟμΙ), С, halopendol 2 5 Mg (0.5 μΐ), D, halo­
pendol S Mg (1 0 μΐ) Number of rats 9 For further legends 
see Fig. 1 
¿/-Amphetamine-Induced Stereotyped Behaviour 
The effects of intracerebral injections into the caudate 
nucleus and into the nucleus accumbens upon stereo-
typed behaviour, induced by (/-amphetamine in a dose 
of 5 mg/kg i.p., are shown in Fig 3. (/-Amphetamine 
induced a pattern of stereotyped behaviour which was 
somewhat different from that following apomorphine 
The onset and finish were more gradual and in these 
phases locomotor stimulation was more prominent 
The stereotyped behaviour reached its maximum after 
about 4 0 - 50mm and lasted in general for more than 
2' 12 hrs. The effect of amphetamine was somewhat 
stronger in the nucleus accumbens-group than in the 
caudate nucleus-group, the difference being signif-
icant (P < 0.05) at 80 and 85 mm following injection 
No significant changes of stereotyped activity were 
found following injection of saline (1 0 μΐ) into the 
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caudate nucleus or into the nucleus accumbens, 
although in the nucleus accumbens-group there was 
a stronger reaction to amphetamine before the injec­
tion of saline (P S 0 05 at IS and 20 mm) In com­
parison to the caudate nucleus-group higher stereo-
typy-scores for the nucleus accumbens-group were 
found at IS and 20 mm (P <, 0 OS), at 85 and 90 mm 
(P <, 0 01) and at 95,100,115 and 120 mm (Ρ <. 0 05) 
Administration of Haloperidol in a dose of 2 5 μg 
(0 5 μΐ) bilaterally into the caudate nucleus decreased 
the amphetamine-induced stereotyped behaviour 
(P 5 0 01 at 30 and 35 mm in comparison to saline, 
Ρ <, 0 05 from 40 to 75 mm and at 150 mm) Injection 
of this dose of halopendol into the nucleus accumbens 
also resulted in a clear reduction of stereotypy, which 
was significant in companson to saline from 35 to 
120 mm and at 145 and 150 mm (Ρ ί 0 01 at 40, 45, 
80, 90,95, 100, 105, 110, 120 and 150mm, P i 0 05 
at 35 mm, at 50 to 75 mm and at 85,115 and 145 mm) 
In companson to the caudate nucleus-group higher 
stereotypy-scores were found in the nucleus accum­
bens-group at 20 and 25 mm (P < 0 05) and lower 
scores at 105 and 110 mm (/• £ 0 05) 
Injection of 5 μg of halopendol (1 0 μΐ) either into 
the caudate nucleus or into the nucleus accumbens 
nearly completely disrupted stereotyped activity 
Although before the injection of halopendol into the 
caudate nucleus higher stereotypy-scores were found 
than before the injection of salme (Z* < 0 05 at 15 and 
20 mm), after the injection of halopendol a significant 
reduction was seen (P <. 0 01 from 25 to 140 mm, 
Ρ < 0 05 at 145 and 150 min) Also with respect to the 
lower dose of halopendol the difference was significant 
(P < 0 05 from 25 to 150 mm, Ρ < 0 01 at 25, 55,60, 
110 and 115 mm) The effect of injection of 5 μg of 
halopendol into the nucleus accumbens was signif­
icantly different from that of saline from 25 to 150 mm 
(P < 005 at 25 and 150min, Ρ á 001 from 30 to 
145 mm) With respect to the lower dose of halopendol 
the difference was significant from 35 to 75 mm 
(P i 0 05) No significant differences were found 
between the caudate nucleus-group and the nucleus 
accumbens-group in this experiment 
Although clearly showing less stereotyped behav-
iour following the injection of halopendol, the behav-
iour of these animals was not normal Within a few 
minutes after the administration of halopendol the 
stereotyped behaviour became more irregular and the 
animals showed more locomotion, often crouching 
aver the floor in a characteristic manner with a flat 
back, alternated with periods of lying or sitting, some-
times immobile, sometimes with mild head-move-
ments There were also periods of grooming and often 
the animals reacted to slight acoustic stimuli Some 
rats showed more rearing or climbed out of the cage 
A few animals reacted within 5 mm after the injection 
of halopendol by suddenly jumping out of the cage 
and then remained for a while lying immobile on the 
table These changes in behaviour were observed in 
both the caudate nucleus-group and the nucleus 
accumbens-group Locomotor stimulation seemed 
somewhat more depressed following injection of 
halopendol into the nucleus accumbens than into the 
caudate nucleus 
Histology 
In the animals which had cannulae intended for the 
caudate nucleus the tips of the needle-tracks were 
found between the antenor planes 7890 μ and 7020 μ 
according to the atlas of König and Klippel (1963) 
Lateral coordinates ranged from 1 4 to 2 6, whereas 
honzontal coordinates varied from 1 8 to 0 0 The 
injection-sites in the nucleus accumbens were found 
between the anterior planes 9820 μ and 8620 μ, 
laterally between 0 7 and 1 6 and horizontally be­
tween 0 0 and - 1 0 
Discussion 
In the present study it was found that intracerebral 
injections of low doses of halopendol (2 5 and 5 μg 
bilaterally) antagonized the stereotyped behaviour, 
induced by apomorphine and ¿-amphetamine Inhibi-
tion of amphetamine-induced stereotyped behaviour 
by intrastnatal injections of halopendol was found 
earlier by Fog et al (1971), who used, however, a dose 
of 100 μg bilaterally and by Costali et al (1972a), 
who found inhibition with doses of 50 and 100 μg, 
but not with 25 μg It might be possible that recovery 
of ether anesthesia, which was used in this last men­
tioned study, during the intracerebral administration 
interferes with the effect of halopendol In our study 
halopendol was given in freely moving animals Also 
Fuxe et al (1970) found a reduction of apomorphine-
and amphetamine-induced stereotyped behaviour fol­
lowing bilateral intrastnatal administration of chlor-
promazine, using low doses 
The effects of halopendol upon apomorphine- and 
upon ¿-amphetamine-induced stereotyped behaviour 
were somewhat different Whereas halopendol shor-
tened the duration of the effect of apomorphine with-
out gross changes in stereotyped behaviour, abnormal 
behavioural patterns such as crawling and suddenly 
jumping were observed following injection of halo-
pendol into animals who had received ¿-amphetamine 
This may be caused by a difference in the activity-
spectra of apomorphine and ¿-amphetamine, since 
amphetamine is known to influence also noradrenergic 
and serotonergic mechanisms (Fuxe et al, 1970) 
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«/-Amphetamine-induced stereotyped behaviour 
was reduced by injection of halopendol into the 
nucleus accumbens as effectively as by administration 
of halopendol into the caudate nucleus The same was 
found with respect to the effect of apomorphme In 
contrast with this, we have previously found that 
J-amphetamine-induced locomotor stimulation is 
antagonized by bilateral injection of low doses of 
halopendol into the nucleus accumbens, but not into 
the caudate nucleus (Pijnenburg et al, 1975) It is 
unlikely therefore, that the inhibitory action of halo-
pendol following injection into the nucleus accumbens 
can be ascribed to a diffusion of this substance to the 
caudate nucleus, the more so as no clear differences 
were found in the latency of the inhibition The 
importance of the mesohmbic dopamine system with 
regard to stereotyped behaviour is also indicated by 
lesion-studies (McKenzie, 1972, Costali et al, 1973 b, 
1974a, b) 
Haloperidol is considered as a rather specific 
dopamine receptor-blocking agent (van Rossum, 1966, 
Anden et al, 1970) Although halopendol also has 
local anesthetic properties (Socman et al, 1974), it 
seems unlikely that these are responsible for the 
inhibition of stereotyped behaviour since administra-
tion of the local anesthetic agent procaine, in contrast 
to halopendol, did not reduce the effects of apomor-
phme It is likely that the effect of procaine is more 
complex than just producing a simple "reversible 
lesion" (Seeman, 1972) However, several authors 
(Divac, 1972, McKenzie, 1972, Costali et al, 1973b, 
Wolfarth, 1974) have also reported that large mechani-
cal or electrolytic lesions of the caudate nucleus do not 
reduce stereotyped behaviour induced by apomor-
phme 
So there seems to be a discrepancy between the 
effects of local injection of halopendol and lesions of 
the neostnatum It might be possible, however, that 
selective inhibition of dopaminergic activity produces 
typical changes (e g disturbance of balance-systems) 
within the neostnatum and possibly also within the 
nucleus accumbens, interfenng with stereotyped 
activity, which are not produced when the whole 
nucleus is lesioned 
Two very recent studies have reported that bilateral 
6-hydroxydopamine lesions of the caudate nucleus 
antagonized stereotyped behaviour, induced by d-
amphetamme, whereas similar lesions of the tuber-
culum olfactonum and nucleus accumbens were 
ineffective in this respect (Asher and Aghajanian, 
1974, Creese and Iversen, 1974) In these studies 
lesions were made at least 2 weeks before the injection 
of J-amphetamine, whereas in our study the effects of 
halopendol were investigated upon ongoing stereo-
typed activity Apart from the fact that local 6-hydroxy-
dopamine lesions may be more aspecific as previously 
supposed (Poirier et al. 1972, Butcher et al, 1974) it 
is conceivable that acute inhibition of dopaminergic 
activity produces changes, different from chronic 
inhibition The fact that in animals, which had received 
¿/-amphetamine, more abnormal behavioural patterns 
were seen following injection of halopendol than 
following 6-hydroxydopamine lesions, may point in 
this direction 
In conclusion, our results indicate that ongoing 
stereotyped behaviour can be antagonized or modified 
by injection of halopendol both into the caudate 
nucleus and into the nucleus accumbens 
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SUMMARY 
Ergometrine was injected in rats intraperitoneally or intravenously and also 
directly into different parts of the brain. After peripheral injection the animals showed 
a characteristic crawling behaviour. This behaviour was reversed by apomorphine. 
Following bilateral injection of ergometrine into the nucleus accumbens, the 
rats showed a biphasic response. After a period, during which sedation and ptosis 
predominated, there followed a strong and long-lasting locomotor stimulation, which 
started and finished in most cases rather abruptly. When the doses of ergometrine 
were lowered the locomotor activity remained at a constant high level, but the dura-
tion was shorter. Bilateral injection of ergometrine into the caudate nucleus or into 
the septum had only little or no stimulant effect on locomotor activity. 
The strong locomotor stimulation following injection of ergometrine into the 
nucleus accumbens was inhibited by low doses of haloperidol and pimozide given 
intraperitoneally. 
Pretreatment with a-methyl-p-tyrosine had no influence on this motor activity. 
Ergometrine injected unilaterally into the nucleus accumbens and into the 
caudate nucleus caused only a slight enhanced locomotor activity and turning to the 
contralateral side. 
The possible mode of action of ergometrine is discussed. 
INTRODUCTION 
Ergometrine has been used widely in therapy as a uterus spasmogen since its 
pharmacological properties were described in detail by Brown and Sir Henry Dale5 
• Present address : Department of Physiology and Biochemistry, University of Southampton, South-
ampton SO 9 SNH, Great Britain. 
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in 1935. They also described a central stimulant action of ergometrine with the 
production of 'sham rage'. A similar effect was reported by Gaddum and Vogt13 
after the injection of 2 mg ergometrine into the lateral ventricle of conscious cats. 
Recently ergometrine has been shown to be a potent antagonist of the inhibitory 
action of dopamine on neurones of the snail Helix aspersa13·™. The effect of dopamine 
on these Helix aspersa neurones appears to be mediated by true dopamine receptors25. 
In the mammalian brain dopamine plays an essential role14. We have considered 
the possibility that some of the central actions of ergometrine in mammals could be 
brought about by an action on dopamine receptors. For this reason we decided to 
investigate some of the central actions of this compound in rats by intracerebral injec­
tions. In this paper we report a strong locomotor stimulant action of ergometrine. 
METHODS 
Intraperitoneal and intravenous injections 
Male Wistar rats were used, weighing 150-200 g, housed in groups of 3, with 
free access to food and water. 
In some experiments groups of 4 rats, each subjected to drug treatment, were 
placed in a semicircular wooden cage with a glass front. The cage had a radius of 
40 cm and a height of 60 cm. In another similar cage 4 untreated or vehicle treated 
animals were placed for comparison. The behaviour of the animals was observed for 
up to 4 h following the injection. 
In other experiments individual animals were placed in a motor activity cage 
(see under apparatus) and locomotor activity was recorded for up to б h after the 
injection. 
Ergometrine maléate, dissolved in saline, was injected intraperitoneally in doses 
of 5.0 and 10.0 mg/kg or intravenously (tail vein) in doses of 1.0, 2.0 and 5.0 mg/kg, 
either alone or followed by apomorphine HCl in a dose of 1.0 mg/kg i.p. about 
20 min later. 
Injections directly into the brain 
Male Wistar rats were used, weighing 200-220 g at the time of operation. Under 
sodium pentobarbital anaesthesia (40 mg/kg i.p.) double barrelled stainless steel 
cannulae were implanted bilaterally into different regions of the brain. The injection 
sites aimed for were: the head of the caudate nucleus in 4 rats (coordinates A 9.4, 
L 2.0, H 1.0 according to the atlas of König and Klippel16); the nucleus accumbens in 
6 rats (coordinates A 9.4, L 1.2, H — 0.6) and the septum in 3 rats (coordinates A 8.0, 
L 0.5, H 0.6). The cannulae placed in the caudate nucleus and the nucleus accumbens 
were brought in from the lateral side at an angle of 10° in order to avoid the ventricles, 
and were fixed on to the skull with acrylic dental cement (Paladur). The cannulae 
placed in the septum were brought in from the contralateral side at an angle of 12.5° 
and also at an angle of 12.5° from the posterior and anterior sides. Two jeweller's 
screws were placed into the skull to firmly attach the cement. The diameter of the 
outer and inner cannulae were 0.65 and 0.30 mm respectively. 
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After surgery the animals were put into individual home cages After a period 
of 2 weeks, in which the animals recovered from the operation and during which time 
they were accustomed to handling, the rats were put into the activity cages several 
times in order to adapt to the new environment. 
Injections were given to the unanaesthetized animals by means of a 5 /il Hamil­
ton syringe with a 31-gauge needle, which extended into the brain tissue 1.5-2 0 mm 
below the tip of the permanently embedded cannula. The rats were injected bilaterally 
and unilaterally. The injection volume was always 0 5 μ\. Ergometrine maléate, dis-
solved in saline, was given in doses of 5.0, 2.0, 1.0, 0.5, 0.1 and 0.01 /ig on each side. 
After replacement of the inner cannulae the animals were placed singly in semicircular 
cages to observe their behaviour or into a motor activity cage, where their locomotor 
activity was recorded for up to 6 h or longer if necessary. Following the injection the 
animals were left to recover for at least 2 days before they were used again. 
In some experiments the animals were pretreated with neuroleptics before the 
intracerebral injection of ergometrine. For this purpose halopendol, dissolved in pro-
pylene glycol, was given intrapentoneally in doses of 0.1 and 0 5 mg/kg 15 and 30 mm 
respectively before the injection of ergometrine Pimozide, dissolved in diluted L ( + ) -
tartanc acid, was injected intrapentoneally in a dose of 0.1 mg/kg 3 h before ergo-
metrine 
The tyrosine hydroxylase inhibitor DL-a-methyl-/?-tyrosine, emulsified with tra-
gacanth, was administered orally in a dose of 200 mg/kg 8 h before the injection of 
ergometrine. 
Apparatus 
Locomotor activity was measured in activity cages, equipped with 3 light sources 
and opposite to them 3 photoelectric cells 2 cm above the floor. The dimensions of 
the cage were 36 cm X 24 cm \ 25 cm. The light beams were arranged in such a 
manner, that one was directed perpendicular to the 2 others and the floor of the cage 
was divided into 6 squares of 12 cm χ 12 cm. The cages were situated in a ventilated 
soundproof box and illuminated with a house light of constant intensity The inter­
ruptions of the light beams were registered on a cumulative Ralph-Gerbrands re­
corder After 500 interruptions the pen of the recorder returned automatically to the 
base line. 
Histological procedures 
After the end of the experiments the animals were perfused first with saline and 
then with 30 ml of a 10% formalin solution through the left cardiac ventricle under 
sodium pentobarbital anaesthesia The brains were removed and kept in a 4 " 0 formalin 
solution for 7 days After that time the brains were dehydrated and embedded in 
paraffin Serial 15 //m thick frontal sections were cut and stained with haematoxylm-
eosm The position of the tips of the needle-tracks were marked on a diagram (see 
Fig. 1) 
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Fig. 1. Frontal sections of the rat brain according to the atlas of König and Klippel16 in which the 
sites of application of ergometrine have been indicated. The numbers 1-6 refer to the rats with 
cannulae in the nucleus accumbens; the numbers 7-10 to rats with cannulae in the caudate nucleus. 
Abbreviations: a, nucleus accumbens; cp, nucleus caudatus putamen; si, nucleus septahs lateralis. 
RESULTS 
Intraperitoneal and intravenous injections 
Ergometrine injected intraperitoneally (5.0 or 10.0 mg/kg) produced a charac-
teristic response about 5-10 min after the injection. There was piloerection and the 
rats adopted a characteristic posture. The rats would crawl slowly round the perimeter 
of the cage with the belly touching the floor and the legs (especially the hind legs) 
extended. The movement was irregular and the rats would frequently stay motionless 
for several seconds before moving on again. When provoked by a sound stimulus the 
rats would temporarily adopt a normal running posture. The effect of ergometrine 
on the posture of the animal normally began to wear off about 60-90 min after the 
injection. In all cases the animals recovered and looked normal the following day. 
A similar effect was observed after the intravenous injection of ergometrine (1.0, 
2.0 or 5.0 mg/kg); in these experiments the effect came on within 1 min of the injection 
and lasted for about 20-60 min. 
When animals treated with ergometrine intraperitoneally or intravenously were 
studied in an activity cage, there was no sign of a strong effect on locomotor activity 
(see Fig. 3B) 
In some experiments, animals which had received ergometrine (5.0 or 10.0 mg/kg 
i.p.) were then injected after about 20 mm with apomorphine (1.0 mg/kg i.p.). The 
effect of the ergometrine was reversed within 5 mm and the animals now showed a 
strong behauoural response to apomorphine, including compulsive gnawing, arching 
of the back. Straub tail's phenomenon and sometimes the bizarre behaviour described 
by Lammers and van Rossum17. In some cases, especially with the higher doses of 
ergometrine, the combination of ergometrine followed by apomorphine was fatal; in 
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Fig. 2. Motor activity of a rat (rat 1) as measured in the activity cage. After a period of adaptation 
to the cage, ergometrine 2.0 /<g bilaterally is injected into the nucleus accumbens (black arrow). 
Following the injection there is a period of low activity. After about 1 h the motor activity increases 
and remains at a high constant level for several hours. 
these animals there were circling movements, much tail-biting and convulsions with 
death, occurring about 30-60 min after the injection of apomorphine. 
Intracerebral injections 
Bilateral injections. After bilateral injection of different doses of ergometrine 
into the nucleus accumbens there was a biphasic response. Within a few minutes after 
the injection the animals showed ptosis and sedation. Further, the animals showed 
signs of shivering, abortive grooming, scratching the body and involuntary movements 
of the legs, the trunk and the head. In a few cases the characteristic crawling move­
ments as seen after intraperitoneal or intravenous injection appeared after intra­
cerebral injection. After a period of 30-60 min following the injection the animals 
began to run and showed a strong locomotor activity. This enhanced locomotor activ­
ity started in most cases very suddenly and lasted for up to 7 or 8 h after the injection 
of 5.0 μ%. Fig. 2 shows the effect of injection of 2.0 /ig bilaterally as measured in the 
activity cage. This phenomenon was observed in all 6 rats with cannulae embedded 
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Fig. 3. A: shows the time course of locomotor activity of a rat (rat S) after injection of 2.0 /ig bi­
laterally into the nucleus accumbens. In this and the following figures the values for motor activity, 
as calculated from the cumulative recording data, are averaged over 5 min periods and plotted. 
B: shows the motor activity of a rat following the injection of ergometrine 10 mg/kg intraperitoneally. 
in the nucleus accumbens. The same rats injected with ergometrine 2 or more days 
later showed a similar locomotor stimulation. The injection of saline (0.5 μΐ bilater­
ally) had no effect on the motor activity (see Fig. 4A). When ergometrine was injected 
into the caudate nucleus the animals also showed ptosis and sedation, and the same 
signs of shivering, abortive grooming and so on were observed. However, relative to 
the effect seen after injection into the nucleus accumbens, there was only a slight 
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Fig. 4. A: motor activity (averaged/5 min) of a rat (rat 4) after the injeclion of 0.5 μ\ saline bilaterally 
into the nucleus aocumbens. B: motor activity (averaged/5 min) of a rat (rat 10) after the injection 
of 5.0 μ% ergometrine bilaterally into the caudate nucleus. C: for comparison the motor activity of 
a rat is shown following the injecticm of D-amphetamine sulphate 1.5 mg/lcg i.p. 
enhancement of motor activity starting about 90 min after the injection of 5.0 μ% 
bilaterally and usually lasting for up to 3-4 h (see Fig. 4B). 
Injection into the septum (2.0 /ig bilaterally) had no stimulant effect on loco­
motor activity. 
Ergometrine in lower doses (1.0 and 0.5 /ig bilaterally) when injected into the 
nucleus accumbens again produced enhanced locomotor activity in all 6 animals. 
However, at these dose levels, although the motor activity, when measured and aver­
aged over 5 min periods, was approximately as high as with a dose of 5.0 /<g bilater­
ally, the duration of the effect was shorter. Thus after the administration of 1.0 /ig 
the motor activity lasted for about 4-5 h. After the injection of 0.5 /ig, locomotor 
activity was increased for about 3-4 h. With even lower doses of ergometrine injected 
into the nucleus accumbens fewer animals responded. After doses ofO.l /ig bilaterally 
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there was locomotor stimulation in only 3 out of 6 animals. In the animals that did 
respond the locomotor stimulation lasted for about 2-3 h. Ergometrine 0.01 /ig was 
only effective in 1 out of 6 animals which showed locomotor stimulation lasting for 
2h. 
When injected into the caudate nucleus in doses of 1.0 /ig or 0.5 /zg bilaterally, 
ergometrine was without stimulant effect on locomotor activity. 
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Fig 5. A : motor activity of a rat (rat 3) following the injection of ergometrine 1 0 /ig bilaterally into 
the nucleus accumbens В motor activity of the same rat, pretreated with pimozide 0 1 mg/kg i.p., 
3 h before the injection of ergometrine. The locomotor stimulation is strongly inhibited. About 3 h 
after the injection of ergometrine there is a slight stimulation of locomotor activity lasting for about 
1 h. 
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In most cases the enhanced locomotor activity induced by injection of ergo-
metrine into the nucleus accumbens started rather abruptly and remained continu-
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Fig 6. А° motor activity ofa rat (rat 6) following the injection of 0.5 /<g ergomelrme bilaterally into 
the nucleus accumbens. B: motor activity of the same rat after pretrealment with haloperidol 0.1 
mg/kg i.p. IS mm before the injection of ergometnne. The locomotor stimulation is completely 
inhibited. 
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ously high for long penods. The cessation of activity was rather sudden and was 
usually preceded by short pauses. It should be noted that during this period of strong 
locomotor activity the animals showed no sign of aggressiveness but, on the contrary, 
could be handled very easily without resistance. When they were handled, they stopped 
their activity and after they had been replaced in the observation cage they resumed 
their running. The motor activity consisted of coordinated movements. The animals 
continuously showed walking, running, rearing or climbing and could easily avoid 
obstacles. When the rats were placed on a table and reached the edge of it, they never 
fell off. During this period of activity very little or no grooming was observed. 
Pimozide (0.1 mg/kg i.p.) given 3 h before the injection of ergometnne (1.0 /ig 
bilaterally) into the nucleus accumbens completely blocked the locomotor stimulant 
effect in 3 out of 6 rats. In 2 other rats, pretreated with this dose of pimozide, ergo-
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Fig 7 Motor activity of a rat (rat 2) following the injection of ergometnne 1 0 μί bilaterally into the 
nucleus accumbens after pretreatment with a-methyl-/>-tyrosine 200 mg/kg orally 8 h before the 
injection of ergometnne. 
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metrine produced only a slight enhancement of locomotor activity which started after 
3 and 3.5 h respectively and which lasted for only 1 h (see Fig. 5). In the remaining 
rat there was no sign of inhibition of the ergometrine effect by pimozide. 
Haloperidol (0.1 mg/kg i.p.), when given 15 min before, completely antagonized 
the locomotor activity after bilateral injection of 0.5 /ig ergometrine in 5 out of 6 rats 
(see Fig. 6). In the remaining rat locomotor stimulation was still produced but only 
after a delay of 100 min. The inhibition by haloperidol was overcome by higher doses 
of ergometrine. The effect of ergometrine, 5.0 μg bilaterally, was inhibited by 0.5 
mg/kg i.p. given 30 min before in only 2 out of 6 rats. 
Injection of the solvents propylene glycol or L(+)-tartaric acid solution had no 
effect on the enhanced activity. 
a-Methyl-p-tyrosine (200 mg/kg orally), administered 8 h before the injection 
of ergometrine (1.0 μg bilaterally) into the nucleus accumbens, had no clear-cut 
effect on the locomotor stimulation in any of the 6 rats (see Fig. 7), although the rats 
were strongly sedated before they received ergometrine. 
Unilateral injections. After unilateral injection of 5.0 μ% ergometrine into the 
nucleus accumbens the animals showed the same phenomena as after bilateral injec­
tions. After a period of 30-60 min they became active. The duration of this activity 
was less than after bilateral injection, lasting for 3-4 h. Also the degree of activity 
was considerably less (see Fig. 8). When the animals started to run they often showed 
turning to the contralateral side (opposite to the side injected). In some animals there 
was only a slight preference for contralateral turning, in other animals this turning 
was very apparent and they turned 10-15 times/min. This contralateral turning was 
also observed, although to a lesser degree, after unilateral injection of 5.0 //g ergo­
metrine into the caudate nucleus. In most cases this turning behavior was of shorter 
duration than the activity period. 
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Fig. 8. Motor activity of a rat (rat 6) following the injection of ergometrine 5.0 /ig unilaterally (left 
side). 
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DISCUSSION 
The crawling behaviour induced by intraperitoneal injection of ergometrme in 
rats is similar to the phenomenon in rabbits and cats reported by Brown and Dale5, 
who concluded that this effect was mediated by a central mechanism. 
A surprising finding in our study was the strong locomotor stimulation following 
the injection of small amounts of ergometrme into the nucleus accumbens When 
injected intrapentoneally or intravenously ergometrme had no such effect It is pos-
sible that ergometrme does not reach the nucleus accumbens in sufficient concentra-
tion following peripheral administration. Alternatively, it is likely that following intra-
peritoneal or intravenous injection any effect of ergometrme on the nucleus accumbens 
can be inhibited or modified by an action of ergometrme on other areas of the brain 
Our results suggest that the nucleus accumbens might be important in controlling 
locomotor activity 
The nucleus accumbens contains a high density of dopamine nerve terminals. 
This nucleus takes part of the so called mesohmbic dopamine system2·3·20 Axons of 
dopamine cell-bodies dorsocranial to the interpeduncular nucleus in the ventral 
mesencephalon (Aio-group according to Dahlstróm and Fuxe10) ascend together 
with axons of the mgrostnatal dopamine system, but follow a more medial route 
The nerve terminals of these axons enter the nucleus accumbens, the nucleus mter-
stitiahs striae termmalis and the tuberculum olfactonum2·3·12·20. 
Little is known about the functional role of this dopamine system Crow9 has 
shown that electrical self-stimulation can be elicited by electrodes in the Аю-сеіі 
group Also the nucleus accumbens is known to be a site for self-stimulation18 In 
contrast to medial forebrain bundle self-stimulation, which influences the activity of 
many brain stem units and causes arousal, stimulation in the nucleus accumbens 
influences only very few brain stem units and causes hypoactivity18. Therefore it is 
difficult to explain the strong locomotor activity after ergometrme injections into 
the nucleus accumbens by an influence on the brain stem reticular formation. 
A remarkable fact is the long latency time with regard to the locomotor stimula­
tion. Usually there is a delay of 30-60 mm after the injections before the animals 
start to run One possibility is that diffusion must take place to a site where the ergo­
metrme is acting However, the injection of ergometrme into surrounding structures 
such as the caudate nucleus and the septum had little or no effect on the locomotor 
activity Moreover, diffusion is dependent on the concentration of the drug, it seemed, 
however, that different concentrations of ergometrme had the same latency time 
Another possibility is that a metabolite of ergometrme is the active component 
Very little is known about the metabolism of ergometrme and other ergot-alkaloids 
With regard to the rather abrupt start and finish of the locomotor activity and also 
to the fact that the activity remains at a constant high level independent of the concen­
tration, it is most likely that some system must be 'triggered' Which system this could 
be is unknown at present In this respect it is worthy of mention that electrical stimula­
tion of the dorbomcdidl posterior hypothalamus consistently produced running, rear­
ing and other "voluntary movements' throughout the stimulation period and that 
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these movements were accompanied by rhythmical slow activity in the hippocampus 
as shown by Bland and Van der Wolf4. 
Ergometrine is a substance, like other ergot-alkaloids, with a rather complex 
mechanism of action. It is known for instance that ergometrine will potentiate the 
action of noradrenaline on the guinea-pig vas deferens preparation24. It is also known 
that ergometrine is a potent antagonist of 5-hydroxytryptamine8. However, methy-
sergide, another antagonist of S-hydroxytryptamine, was ineffective in producing 
locomotor stimulation (unpublished observation). As already mentioned in the intro-
duction, ergometrine inhibits the dopamine response in the snail brain. In the rat, 
ergometrine injected intraperitoneally or intravenously was unable to inhibit the 
behavioural effects of apomorphine. 
The locomotor stimulation was blocked by low doses of Haloperidol and pimo-
zide. Haloperidol is a potent antagonist of the stereotyped behaviour induced by 
amphetamine11·22 and also antagonizes the behavioural effects produced by injection 
of dopamine into the caudate nucleus of conscious cats*·7. Haloperidol and pimozide 
in low doses are believed to block dopaminergic receptors in mammals1·15·21·22. It is 
therefore quite possible that dopaminergic receptors are involved in this action of 
ergometrine. A presynaptic action is unlikely, because pretreatment with a-methyl-p-
tyrosine, which causes a depletion of dopamine and noradrenaline in the brain19, had 
no influence. However, other mechanisms of action cannot be ruled out. 
Further experiments to elucidate the mode by which ergometrine causes this 
strong and long-lasting motor activity are in progress. 
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ABSTRACT 
The influence of different pretreatments upon ІосопюСог stimulation, 
induced by injection of ergometrine into the nucleus accumbens of rats, 
was investigated. The noradrenergic antagonists phenoxybenzamine and 
propranolol and the serotonin antagonist methysergide produced no clear 
changes. Reserpine, alone or in combination with a-MPT, considerably 
shortened the delay between injection of ergometrine and start of loco­
motor stimulation. Ro-DOPA, but not Ro-5-HTP, clearly antagonized the 
locomotor stimulation. The effect of ergometrine was strongly diminished 
following injection of haloperidol directly into the nucleus accumbens. 
A strong inhibition was also observed following intracerebral adminis­
tration of the imidazoline derivative (3t4-dihydroxy-phenylamino)-2-
imidazoline (DPI), but not after injection of the structurally related 
compound Clonidine. DPI by itself and also the ergot derivatives ergo-
cornine, bromocryptine, LSD, dihydroergotamine and methysergide in doses 
5-10 times as high as that of ergometrine failed to produce locomotor 
stimulation following injection into the nucleus accunfcens. The results 
are discussed especially with regard to the role of dopamine. 
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INTRODUCTION 
Recently we have reported that bilateral injection of ergometrine into 
the nucleus accumbens of rats produced a long-lasting stimulation of 
locomotor activity (1). This effect was similar to that following injec-
tion of dopamine into this nucleus after nialamide-pretreatment (2, 3) 
and could be antagonized by low doses of the neuroleptic drugs haloperi-
dol and pimozide, but not by the catecholamine synthesis-inhibitor 
a-methyl-p-tyrosine (1). Dopamine-like actions of ergometrine in the 
rat brain have also been suggested on the basis of studies on circling 
behaviour following unilateral 6-hydroxydopamine (6-OH-DA) lesions of 
the substantia nigra (4) and on stimulation of dopamine-sensitive 
adenylate cyclase (5). Also the inhibition of prolactin release by ergo-
metrine (6, 7) may be caused by a dopamine-like'action (8). 
However, the mechanism of action of ergometrine may be more complex. 
Since ergometrine is a potent serotonin antagonist (9) and also has 
adrenergic stimulant properties (10) the possibility exists that these 
other monoamines might play an additional role in the above mentioned 
locomotor stimulant action of ergometrine. Furthermore, it is remarkable 
that no dopamine-like, but only dopamine blocking actions of ergometrine 
were found in studies on snail neurones (11, 12, 13), on the renal blood 
flow in the dog (14) and also on the cat brain (Cools, to be published; 
see also discussion). 
The present study was performed, therefore, in order to investigate 
the role of some other neurotransmitters in the ergometrine-induced loco-
motor stimulation and to further explore the role of dopamine. Moreover, 
we wanted to study whether also other ergot derivatives, especially ergo-
comine and bromocryptine, which have been reported to possess dopamine 
agonistic properties in the rat brain (16) would produce locomotor sti-
mulation following injection into the nucleus accumbens. 
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METHODS 
Intraoerebral injections 
Male Wis tar rats were used, weighing 200 +_ 20 gram at the time of opera­
tion. Under sodium pentobarbital anaesthesia (АО mg/kg, i.p.) double 
barrelled stainless steel cannulae with an outer and inner diameter of 
0.65 and 0.30 mm respectively were stereotaxically implanted into the 
nucleus accumbens. The injection sites chosen had the following coor­
dinates, according to the atlas of König and Klippel (17): A 9.4, L 1.2 
and H -0.6. Cannulae were brought in from the lateral side at an angle 
of 10 with the midsagittal plane in order to avoid the ventricular 
system and fixed on to the skull with acrylic dental cement (Faladur). 
Following surgery the rats were housed in individual cages with free 
access to food and water. Illumination was present from 6.00 a.m. to 
6.00 p.m. 
The experiments were started after a period of at least 10 days. 
During that period the rats were accustomed to handling and adapted to 
the activity cages. Intracerebral injections were given bilaterally 
(without anaesthesia) by means of a 5 μΐ Hamilton syringe with a 31 
gauge needle, which extended into the brain tissue 1.0-1.5 mm below the 
tip of the permanently implanted cannula. The injection volume was 
always 0.5 μΐ on each side. At least 3 days of rest were given between 
the different treatments. 
Measurement of loocmotor activity 
Locomotor activity of individual rats was measured in activity cages 
equipped with 3 photoelectric cells 2 cm above a grid floor. The dimen­
sions of the cages were 36 cm χ 24 cm χ 25 cm. The interruptions of the 
lightbeams were registered on a cumulative Ralph-Gerbrands recorder. 
After an adaptation period of about one hour to the activity cages loco­
motor activity was continuously recorded during a period of at least 
5 hours following the intracerebral injection. 
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Drugs 
The following drugs were used: ergometrine maléate; 2-Br-a-ergocryptine 
methanesulphonate (CB 154, bromocryptine) ; ergocomine hydrogenmaleinate; 
dihydroergotamine mesylate; D-lysergic acid diethylamide (LSD); methy-
sergide bimaleinate; phenoxybenzamine hydrochloride; 1-propranolol; 
scopolamine hydrobromide; L-0-3,4-dihydroxyphenylalanine (L-DOPA) ; 
DL-5-hydroxytryptophan (5-HTP); N-(DL-seryl)-N'-(2,3,4-trihydroxybenzyl) 
hydrazine hydrochloride (Ro 4-4602); DL-a-methyltyrosine methylester 
hydrochloride (o-MPT) ; reserpine (Serpasil^; haloperidol (Serenase ) ; 
Clonidine hydrochloride; apomorphine hydrochloride; (3,4-dihydroxy-
phenylamino)-2-imidazoline (DPI). 
The doses used refer to the form indicated above. Drugs were dis-
solved in saline, except ergocomine and bromocryptine, which were dis-
solved in 50% propylene glycol. Since preliminary experiments had ex-
cluded a possible effect of the solvents of reserpine and haloperidol, 
these drugs were used in commercial form. 
Histology 
At the end of the experiments 0.5 μΐ of an ink solution was injected to 
verify the site of injection in the brain. The rats were perfused with 
saline and a 10% formalin solution through the left cardiac ventricle 
under sodium pentobarbital anaesthesia. The brains were removed and kept 
in a 4% formalin solution for at least 7 days and were then sectioned 
for control of the site of injection. In all animals the injection sites 
were found within the boundaries of the nucleus accumbens as depicted in 
the atlas of König and Klippel (17). The coordinates of the injection 
sites varied from 8.9 to 9.6 in anterior direction, from 0.6 to 1.6 
laterally and from -0.2 to -1.2 in the depth. 
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RESULTS 
As also previously found (1) bilateral injection of ergometrine into the 
nucleus accumbens produced a strong stimulation of locomotor activity. 
When repeated injections of ergometrine were given with an interval of a 
few days the locomotor stimulation was in general somewhat stronger at 
the second or third injection but then remained rather stable. Some rats, 
when injected with ergometrine a few days earlier, showed a clear loco­
motor stimulation upon administration of saline into the nucleus accum­
bens. It is likely that this effect of saline was produced by some 
residual ergometrine, since neither a second injection of saline nor 
administration of saline before animals had received ergometrine did 
result in locomotor stimulation. In the present experiments, therefore, 
rats received at least two injections of ergometrine before the effects 
of other drugs were tested and between different treatments saline was 
administered into the nucleus accumbens. 
Influenae of varioua drugs upon ergometrine-induced loeomotor stimulation 
In the following experiments a standard dose of 1 ug of ergometrine was 
administered bilaterally. 
As can be seen from fig. 1A neither the α-adrenergic antagonist 
phenoxybenzamine (5 mg/kg, i.p.) nor the g-adrenergic antagonist pro­
pranolol (5 mg/kg, i.p.) profoundly influenced the effect of ergometrine. 
There was perhaps a slight initial depression, which was most clear in 
the case of propranolol. 
Apart from a slight shortening of the duration of locomotor stimula­
tion, also the serotonergic antagonist methysergide (5 mg/kg, i.p.) had 
no clear influence (fig. 1B2). Ergometrine, which is by itself also a 
potent serotonin antagonist (9), does not produce locomotor stimulation 
when administered peripherally (1). Since one of the reasons might be 
that an effect upon the nucleus accumbens is masked by actions of ergo­
metrine upon other sites, in another group of rats also the effect of 
ergometrine administered peripherally (2 mg/kg, i.p.) immediately after 
the central administration of ergometrine was investigated. Although 
locomotor stimulation was not inhibited, this combination proved very 
toxic; 8 of the 9 animals of this group died rather suddenly between 
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Fig. 1. Mean locomotor activity of rats following bilateral injection 
of 1 \ig of ergometrine into the nucleus acaumbens. Vertical 
bars represent S. E. M. ; A and В refer to two different groups 
of rats. Ergometrine was administered at time 0. 
Al: without pretreatment (9 rate); A2: S min after phenoxy-
benzamine S mg/kg, i.p. (9 rats); A3: S min after propranolol 
5 тд/кд, i.p. (9 rats); 
Bl: without pretreatment (9 rats); B2: 10 min after methysergide 
5 тд/кд, i.p. (9 rats); B3: 10 min after scopolamine 1 тд/кд, 
i.p. (7 rats). 
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1 and 2 hours after the injection. 
The anticholinergic agent scopolamine (1 mg/kg, i.p.) produced an 
initial enhancement of locomotor activity (fig. 1ВЭ). This effect was 
more pronounced with a high dose (15 mg/kg, i.p.) of scopolamine (data 
not shown). 
As reported previously (1) the effect of ergometrine could not be 
inhibited by pretreatment with the catecholamine synthesis-inhibitor 
α-МРТ. In the present experiments also pretreatment with the storage 
depleting agent reserpine (2 mg/kg, i.p.) did not inhibit the locomotor 
stimulation. On the contrary, the effect of ergometrine was rather 
potentiated and especially the time of latency was clearly reduced, 
nearly all animals showing strong stimulation of locomotor activity 
within 5-10 min after injection of ergometrine (fig. 2A2). This inme-
diate stimulation was also observed when reserpine was given in combina­
tion with a-MPT (100 mg/kg, i.p.) (fig. 2A3). After completion of this 
experiment 4 animals of this group received further injections of ergo­
metrine at weekly intervals. It was found thereby that the reduced time 
of latency persisted for at least 3 weeks after the last reserpine ad­
ministration. 
In fig. 2B the effects of pretreatment with monoamine-precursors 
are shown. A clear reduction of locomotor stimulation, especially in the 
beginning phase, was seen when L-DOPA (50 mg/kg, i.p.) in combination 
with the peripheral DOPA-decarboxylase inhibitor Ro 4-4602 (50 mg/kg, 
i.p.) was given before ergometrine (fig. 2B2). In these animals activity 
was already depressed at the moment of ergometrine injection. Inhibition 
of locomotor stimulation was not observed after pretreatment with 5-HTP 
(50 mg/kg, i.p.) in combination with Ro 4-4602 (fig. 2B3). The influence 
of apomorphine was investigated in 3 other animals. Administration of 
apomorphine (2 mg/kg, i.p.) about 10 min after the onset of ergometrine-
-induced locomotor stimulation produced within 5-10 min stereotyped 
behaviour, characteristically restricted to the same place of the ob­
servation cage. After about one hour, when the stereotypy diminished, 
these animals resumed their enhanced locomotor activity. 
We had already previously found that the effect of ergometrine was 
inhibited by peripheral administration of low doses of haloperidol (1). 
In the present study we found that the ergometrine-induced locomotor 
stimulation was also clearly reduced when haloperidol (2.5 yg bilaterally) 
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0 1 2 Э 4 5 б 
Fig. 2. Mean locomotor activity of rats following bilateral injection 
of 1 vg of ergometrine into the nucleus accumbens. Vertical 
bars represent S.E.M.; A and В refer to too different groups 
of rats. Ergometrine was administered at time 0. 
Al: without pretreatment (9 rats); A2: 24 h after reserpine 
2 mg/kg, i.p. (8 rats); AS: 24 h after reserpine 2 mg/kg, i.p. 
and 6 h after a-MPT 100 mgfkg, i.p. (9 rats); 
Bl: without pretreatment (4 rats); B2: SO min after Ro 4-4602 
50 mg/kg, i.p. and 20 min after L-DOPA SO mg/kg, i.p. (4 rats); 
B3: SO min after Ro 4-4602 SO mg/kg3 i.p. and 20 min after 
DL-S-HTP SO mg/kg, i.p. (4 rats). 
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Fig. 3. Mean locomotor activity of pate following bilateral injectione 
into the nucleus accwibene. Vertical bare represent S.E.M. 
a) ergometrine, 1 vg (S rate); b) ergometrine, 1 vg, 20 min 
after ealine 0.5 \¡l (9 rats); с) ergometrine, 1 vg, 20 min 
after haloperidol 2.5 vg (9 rats); d) ergometrine, 1 vg, 20 min 
after (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI) 5 vg 
(9 rats); e) ergometrine, 1 vg, 20 min after Clonidine 5 vg 
(8 rats); f) saline, 0.5 vl (9 rats); g) DPI, 5 vg (9 rats). 
In a) - e) ergometrine was administered at time 0. 
Note the different ordinate scale in f) and g). 
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was administered into the nucleus accumbens (fig. 3c). Also injection 
of the imidazoline derivative DPI (5 yg bilaterally) into the nucleus 
accumbens strongly inhibited the effect of ergometrine (fig. 3d), 
whereas this compound by itself had no clear effect upon locomotor 
activity (fig. 3g). The structurally related compound Clonidine (5 yg 
bilaterally) produced only a slight reduction of ergometrine-induced 
activity (fig. 3e). 
Intraeerebral injection of other ergot derivatives 
Since ergocomine and bromocryptine showed a poor water-solubility, 
these drugs were dissolved in 50% propylene glycol. Injection of this 
solvent into the nucleus accumbens resulted in a depression of activity, 
followed by a slight stimulation (fig. 4A1). Administration of 5 and 
10 yg doses of ergocomine and bromocryptine hardly produced any loco-
motor stimulation. The effects of the 10 yg doses are shown in figs. 
4A2 and 4A3 respectively. Ergometrine, however, when dissolved in pro-
pylene glycol, produced a strong locomotor stimulation, although a de-
pressant influence of the solvent seemed apparent, especially in the 
beginning phase. The other ergot derivatives tested were dissolved in 
saline. Doses of 2 and 5 yg of LSD, dihydroergotamine and methysergide 
did not produce a clear locomotor stimulation. The effects of the 5 yg 
doses are shown in fig. 4B. 
DISCUSSION 
In agreement with previous findings (1) bilateral injection of ergo-
metrine into the nucleus accumbens resulted in a strong stimulation of 
locomotor activity. This effect was not or only slightly reduced by 
pretreatment with noradrenergic or serotonergic antagonists. Since also 
pretreatment with Ro-5-HTP or para-chloro-phenylalanine (unpublished 
observation) did not clearly influence the effect of ergometrine and 
since also direct injections of noradrenergic agonists and serotonin 
into the nucleus accumbens did not produce locomotor stimulation in 
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nucleus aocimbens. Vertical bars represent S.E.M.; A and В 
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metrine, S vg (9 rats); 
Bl: saline, 0.5 vl (9 vats); BZ: LSD, 5 y^ (8 rats); BZ: di-
hydroergotamine, 5 vg (9 rats); B4: Methysergide, 5 vg (9 rats). 
In A 50% propylene glycol was used as solvent, in В saline. 
Note the different ordinate scale in A4. 
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contrast to dopamine (18), it is unlikely that noradrenaline and sero-
tonin play a major role in this effect of ergometrine. Although direct 
injection of the cholinergic stimulant carbachol produced enhanced 
activity (18), it is unlikely that the effect of ergometrine is brought 
about by cholinergic stimulation, since pretreatment with the anti-
cholinergic agent scopolamine did not antagonize this effect. 
Locomotor stimulation, which usually started with a delay of 30-60 
min following the injection of ergometrine, started much earlier when 
the animals were pretreated with reserpine. This finding makes it un-
likely that the delay is due to diffusion of ergometrine to a site, 
where it would be active or due to the time necessary for the formation 
of an active metabolite. The fact that the ergometrine-induced locomotor 
stimulation was neither antagonized after depletion of monoamines with 
reserpine, nor after inhibition of catecholamine synthesis with a-MPT 
(I) may indicate a postsynaptic action. However, since Ro-DOPA clearly 
reduced the effect of ergometrine, especially in the beginning phase, 
and since reserpine shortened the delay, the possibility exists that 
also the presynaptic state (loaded or depleted stores) in an as yet un-
explained way is important. Effects of Ro-DOPA and reserpine upon other 
brain sites, however, cannot be excluded at the moment. It must be 
remarked that with respect to the influence of reserpine and L-DOPA, 
ergometrine resembles apomorphine and also d-amphetamine. Reserpine has 
been reported to reduce the time to peak-activity in d-amphetamine-
-induced locomotor stimulation (19) and to potentiate the apomorphine-
-induced stereotyped behaviour (20), whereas L-DOPA has been found to 
reduce stereotyped behaviour, induced by apomorphine and d-amphetamine 
(21). Since, in agreement with our previous finding that the effect of 
ergometrine could be antagonized by peripheral administration of the 
dopamine antagonist haloperidol (1), also administration of haloperidol 
directly into the nucleus accumbens clearly reduced the effect of ergo-
metrine, these results further suggest a dopamine stimulant effect of 
ergometrine. 
It was therefore somewhat unexpected that other ergot derivatives 
failed to induce locomotor stimulation following injection into the 
nucleus accumbens. Ergocomine and bromocryptine have been reported to 
have effects on circling behaviour in rats with unilateral 6-OH-DA-
-induced lesions of the substantia nigra and on dopamine turnover, which 
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are similar Co those produced by the known dopamine agonist apomorphine 
(16). Also the inhibition of prolactin release produced by ergocomine, 
bromocryptine and other ergot derivatives (6, 7, 22) resembles that 
following administration of dopamine or apomorphine (8). Moreover, 
bromocryptine has been reported to be effective in Parkinson's disease 
(23, 24). Also LSD, but not BOL-148 and methysergide, produces contra­
lateral turning in animals with unilateral 6-OH-DA lesions (25), whereas 
both agonist and antagonist effects of LSD have been reported upon 
dopamine-stimulated adenylate cyclase (26, 27, 28). Although in most of 
these studies no direct comparison was made, ergocomine, bromocryptine 
and LSD seemed in general more potent than ergometrine in these models. 
Since in the present study doses 5-10 times as high as that of ergo-
metrine were used, one would have expected an effect. A possible in­
fluence of the solvent propylene glycol upon the effects of ergocomine 
and bromocryptine cannot be excluded. However, although propylene glycol 
also suppressed the effect of ergometrine, locomotor stimulation was 
still produced. 
Another finding, which indicates that the mechanism of action of 
ergometrine may be more complex, is the nearly complete inhibition of 
ergometrine-induced locomotor stimulation following the injection of 
the imidazoline derivative DPI into the nucleus accumbens. It is un­
likely that the inhibition can be ascribed to the α-adrenergic stimulant 
properties of DPI (29), since a comparable dosis of the structurally 
related α-adrenergic agonist Clonidine only slightly inhibited the ef­
fect of ergometrine. Because injection of DPI into the nucleus accumbens 
also inhibited locomotor stimulation, induced by peripheral administra­
tion of d-amphetamine (Cools, to be published) the question raises 
whether DPI could be considered as a dopamine antagonist. It was found, 
however, that DPI mimicked actions of dopamine both in the snail and in 
the cat brain. Studies on snail neurones have revealed the existence of 
more than one type of dopamine receptor. Excitatory respectively in­
hibitory actions of dopamine on neurones of the snail Helix aspersa are 
mimicked selectively by apomorphine respectively DPI, whereas neuroleptic 
drugs selectively antagonize the excitatory actions of dopamine (13, 30). 
Ergometrine is a very potent antagonist of the inhibitory actions of 
dopamine on these snail neurones (11, 12, 13) and also inhibits, although 
less potent, the excitatory actions of dopamine (Struyker Boudier, to be 
92 
published). Also in the cat brain there is evidence for more than one 
type of dopamine receptor (15, 31). DPI and ergometrine mimiek resp. 
block the action of dopamine in only one of two functionally distinct 
dopamine-sensitive areas in the caudate nucleus, whereas apomorphine 
and neuroleptic drugs have corresponding effects in the other dopamine-
-sensitive areas (Cools, submitted for publication). Both in the snail 
brain and in the cat brain ergometrine was found to antagonize the 
actions of DPI. Although other actions of DPI at the moment cannot be 
excluded, the present results point to the possibility, that also in 
the rat brain there exist pharmacologically distinct dopamine actions. 
It must be remarked that DPI by itself did not produce locomotor sti-
mulation following injection into the nucleus accumbens. In contrast, 
the tetralin derivative 2-amino-6,7-dihydroxy-l,2,3,4-tetrahydronaph-
thalene (ADTN), which mimicks not only the inhibitory (32) but also the 
excitatory (Woodruff, personal communication) actions of dopamine upon 
snail neurones, has been reported to produce a strong and long-lasting 
locomotor stimulation following injection into the nucleus accumbens 
(33). 
In conclusion, although the locomotor stimulant effect of ergo-
metrine, which is similar to that of dopamine in nialamide-pretreated 
rats and which is inhibited by Haloperidol, may suggest a dopamine 
agonistic action, the inhibition of the ergometrine effect by DPI and 
also the failure of other ergot derivatives to produce locomotor sti-
raulation indicate that the mechanism of action of ergometrine may be 
more complex. Further investigations on the way, in which ergot deriva-
tives and DPI interfere with dopaminergic systems in the rat brain, 
therefore, are needed. 
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SUMMARY 
From the literature it is known that dopamine plays an important role 
in neurotransmission processes in the brain. An interaction with dopa-
minergic mechanisms has been reported for several psychopharmacological 
agents, e.g. L-DOPA, which is used in the treatment of Parkinson's 
disease; neuroleptic drugs, used in the treatment of psychoses, notably 
schizophrenia; and psychostimulants like amphetamine. In view of the 
fact that there are different dopaminergic systems in the brain, it may 
be important to understand the functional significance of each of these 
systems and to know their respective role in the mechanism of action of 
psychopharmacological agents. 
It was the aim of the experiments, described in this thesis, to 
contribute to the insight in the significance of one of these systems, 
viz. the mesolimbic dopamine system. For this purpose drugs were stereo-
taxically applied into the nucleus accumbens, which is a main terminal 
area of the mesolimbic dopamine system, using the rat as an experimental 
animal. 
In Section I the effects of bilateral injections of dopamine into 
the nucleus accumbens were investigated. Furthermore experiments were 
performed in order to see whether the observed effects were dopamine-
-specific. It was found that administration of dopamine to rats, pre-
treated with the monoamine oxidase-inhibitor nialamide, resulted in a 
strong and long-lasting enhancement of locomotor activity. A similar 
effect, although less intense, was observed following injection of nor-
adrenaline. The fact that the effects of both dopamine and noradrenaline 
could be inhibited by the dopamine antagonist Haloperidol but not by 
noradrenaline antagonists, suggests that the enhanced activity is brought 
about by dopaminergic rather than noradrenergic mechanisms. Further sup-
port for this assumption was found in experiments with rats, which were 
not pretreated with nialamide. In these animals noradrenaline and nor-
adrenaline agonists, in contrast to dopamine, did not produce enhanced 
activity. Also dopamine metabolites were found to be ineffective. 
d-Amphetamine, however, induced a clear locomotor stimulation and the 
same effect, although less consistent, was observed following admini-
stration of the dopamine agonist apomorphine. Finally, some experiments 
suggested that dopaminergic stimulation of the tuberculum olfactorium 
also results in enhanced locomotor activity. Some caution with regard 
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to this conclusion is warranted, however, since injections into this 
area offer special technical problems. 
Section II presents studies concerning the respective role of the 
mesоlimbiс and the nigro-neostriatal dopamine system with respect to 
behavioural effects of peripherally administered d-amphetamine and 
apomorphine. It was found that the locomotor stimulation, induced by 
intraperitoneal injection of d-amphetamine, could be antagonized by ad­
ministration of haloperidol into the nucleus accumbens, but not when 
haloperidol was given into the caudate nucleus. Together with the finding 
that also local application of d-amphetamine into the nucleus accumbens 
induces enhanced locomotor activity, this result provides strong evidence 
for the view that the mesolimbic dopamine system is closely involved in 
the locomotor stimulant actions of d-amphetamine. Both injections of 
haloperidol into the nucleus accumbens and into the caudate nucleus re­
duced the stereotyped behaviour, induced by intraperitoneal administra­
tion of apomorphine and higher doses of d-amphetamine. 
Section III deals with studies concerning the effects of ergometrine 
and some other ergot derivatives, of which an interaction with dopaminer­
gic mechanisms is described. Bilateral administration of ergometrine into 
the nucleus accumbens was found to result in a strong and long-lasting 
stimulation of locomotor activity. When ergometrine was given peripherally 
or into the caudate nucleus no such effect was observed or only to a 
slight extent. The enhanced activity could be inhibited by the dopamine 
antagonists haloperidol and pimozide but not by the catecholamine syn­
thesis-inhibitor а-шеthy1-p-tyrosine. This result might indicate that 
ergometrine in the rat brain has dopamine stimulant properties. Other 
ergot derivatives like ergocomine and bromocryptine, however, failed 
to induce locomotor stimulation following injection into the nucleus 
accumbens. Moreover, the effect of ergometrine was clearly antagonized 
by the imidazoline derivative DPI, a compound which has been reported 
to possess dopamine-mimetic properties in the snail and in the cat brain. 
It must be concluded, therefore, that the mechanism of action of ergo­
metrine seems to be more complex. 
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SAMENVATTING 
Uit litteratuurgegevena blijkt dat dopamine een belangrijke rol speelt 
bij neurotransmissie processen in de hersenen. Diverse psychofarmaca 
blijken met dopaminerge mechanismen te interfereren. In dit verband 
kunnen o.a. genoemd worden: L-DOPA, gebruikt bij de behandeling van de 
ziekte van Parkinson; neuroleptica, toegepast bij de behandeling van 
psychosen, т.п. schizophrénie; psychostimulantia zoals amphetamine. 
Gezien het feit dat er in de hersenen verschillende dopaminerge systemen 
zijn aangetoond, is het van belang de functionele betekenis van ieder 
van deze systemen te leren kennen en te weten wat hun rol is in het 
werkingsmechanisme van deze psychofarmaca. 
Het doel van de experimenten, beschreven in dit proefschrift, was 
het inzicht te verruimen in de betekenis van een van deze systemen, nl. 
het mesolimbisch dopamine systeem. Hiervoor werden bij de rat, met be-
hulp van stereotactische technieken, farmaca toegediend in de nucleus 
accumbens, een belangrijk projectiegebied van dit mesolimbisch dopamine 
systeem. 
In Sectie I werd het effect onderzocht van bilaterale injectie van 
dopamine in de nucleus accumbens. Tevens werd nagegaan in hoeverre het 
gevonden effect specifiek was voor dopamine. Hierbij bleek dat toe-
diening van dopamine aan ratten, die voorbehandeld waren met de mono-
amine oxidase-remmer nialamide, een sterke en langdurige verhoging van 
de motorische activiteit te zien gaf. Eenzelfde effect, zij het in 
mindere mate, werd ook gevonden na injectie van noradrenaline. Het feit 
dat zowel het effect van dopamine als dat van noradrenaline geremd kon 
worden door de dopamine antagonist haloperidol en niet door noradrena-
line antagonisten doet vermoeden dat dopaminerge mechanismen primair 
van belang zijn bij het ontstaan van dit effect. Verdere aanwijzingen 
hiervoor werden gevonden in experimenten met ratten, die niet met nia-
lamide waren voorbehandeld. Hierbij bleken noradrenaline en noradrena-
line agonisten, in tegenstelling tot dopamine, geen verhoogde motorische 
activiteit op te wekken. Wel werden duidelijke effecten verkregen met 
d-amphetamine en, hoewel minder consistent, ook met de dopamine agonist 
apomorphine. Verder werden aanwijzingen gevonden dat mogelijk ook dopa-
minerge stimulatie van het tuberculum olfactorium resulteert in een ver-
hoogde motorische activiteit. Enige voorzichtigheid ten aanzien van deze 
conclusie is echter op zijn plaats in verband met de technische problemen 
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bij injecties in dit gebied. 
In Sectie II werd bestudeerd welke rol het mesolimbisch dopamine 
systeem speelt in vergelijking met het nigro-neostriatale systeem bij 
gedragseffecten, opgewekt door perifere toediening van d-amphetamine en 
apomorphine. Hierbij bleek dat de stimulatie van locomotorische activi­
teit na intraperitoneale injectie van d-amphetamine geantagoneerd kon 
worden door toedienen van Haloperidol in de nucleus accumbens, echter 
niet door toedienen in de nucleus caudatus. Samen met de bevinding dat 
ook locaal inbrengen van d-amphetamine in de nucleus accumbens verhoogde 
motorische activiteit induceert, is dit een sterke aanwijzing dat het 
mesolimbisch dopamine systeem nauw betrokken is bij de locomotorisch 
stimulerende eigenschappen van d-amphetamine. Stereotype gedrag, opge­
wekt door intraperitoneale toediening van apomorphine en van d-ampheta­
mine in hogere dosering, kon worden gereduceerd door injectie van 
haloperidol zowel in de nucleus accumbens als in de nucleus caudatus. 
In Sectie III werd een onderzoek verricht naar de effecten van 
ergometrine en enkele andere ergot derivaten, waarvan een werking op 
dopaminerge mechanismen is beschreven. Bilaterale injectie van ergo­
metrine in de nucleus accumbens veroorzaakte een sterke en langdurige 
verhoging van de motorische activiteit. Dit effect werd niet, of in 
veel mindere mate, waargenomen wanneer ergometrine perifeer of in de 
nucleus caudatus werd toegediend. De verhoogde activiteit kon worden 
geremd door de dopamine antagonisten haloperidol en pimozide, maar niet 
door de catecholamine synthese-remmer α-methy1-p-tyrosine. Dit kan erop 
wijzen dat ergometrine in de hersenen van de rat dopamine stimulerende 
invloeden uitoefent. Omdat echter na injectie van andere ergot derivaten, 
o.a. ergocomine en bromocryptine, in de nucleus accumbens geen verhoogde 
activiteit werd gezien, alsmede omdat het effect van ergometrine duide­
lijk werd geremd door het imidazoline derivaat DPI, een stof waarvan 
dopamine-mimetische eigenschappen zijn beschreven in de hersenen van de 
slak en de kat, moet geconcludeerd worden dat het werkingsmechanisme van 
ergometrine waarschijnlijk meer gecompliceerd is. 
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SAMENVATTEND OVERZIOfT 
Uit diverse oiiderrockcn is vast konrn te staan dat bij de ovcrdrachit 
van elcctrische unpulsen in het zenuwstelsel bepaalde chamsche 
stoffen, neurotransmitters genaamd, een belangrijke rol spelen. Een 
Vein deze stoffen is dopamine, dat vosmamelijk wordt aangetroffen in 
het centrale deel van het zenuwstelsel. Men neemt aan dat psychofar-
maca hun effect uitoefenen door een inwerking op deze neurotransmitters. 
Sormugc van deze f amaca beïnvloeden vooral het dopamine. Een bekend 
voorbeeld hiervan is L-DOPA. Bi] de ziekte van Parkinson bestaat er in 
de hersenen een tekort aan dopamine, hetgeen in belangrijke mate ver-
antwoordelijk wordt gesteld voor de verschijnselen van de ziekte. Bij 
de behandeling van patiënten met de ziekte van Parkinson wordt de 
laatste tijd getracht dit tekort aan te vullen. Omdat dopamine zelf, 
wanneer het wordt toegediend, nauwelijks in de hersenen doordringt, 
gebruikt men hiervoor L-DOPA, een stof die veel genakkelijKer in de 
hersenen komt en daar wordt cmgezet in dopamine. Een ander voorbeeld 
van psychofamaca, die vooral het dopamine beïnvloeden, zijn de z.g. 
neuroleptica, waartoe diverse groepen stoffen met verschillende che-
mische samenstelling behoren. Men veronderstelt dat deze stoffen het 
aangrijpingspunt waar dopamine zijn werking uitoefent, de dopamine 
receptor, blokkeren. Deze neuroleptica blijken een gunstige werking 
uit te oefenen bij patiënten die lijden aan bepaalde vormen van 
psychosen, т.п. schizophrénie. Ook bij de werking van anphetamine en 
daaraan verwante stoffen blijkt dopamine een belangrijke rol te spelen. 
Deze stoffen zijn namelijk in staat om dopanme vrij te maken uit het 
zenuwuiteinde en ook de heropname van dopamine in de zenuwcel te rem-
men, met als gevolg dat het gehalte aan dopamine op de receptorplaats 
wordt verhoogd. De hierdoor ontstane verhoogäe dopaminerge activiteit 
blijkt zich bij proefdieren te uiten in verschijnselen als verhoogde 
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motorxsche activiteit en stereotypie, een gedragspatroon waarbi] be­
paalde elerenten van het nomole gedrag, zoals snuffelen, likken en 
knagen, op een karakteristieke wijze worden herhaald. 
Sinds gevonden werd dat het gehalte aan dopamine in diverse delen 
van de hersenen verschilt, zijn vele experimenten verricht, die uit­
eindelijk hebben geleid tot een vrij gedetailleerde beschrijving van 
het verloop van dopaminerge banen m de hersenen. Naast het mgro-neo-
striatale dopamine systeem, waarvan de cellichamen gelegen zijn in de 
substantia nigra en de zenuwuiteinden zich vertakken in de nucleus 
caudatus en het putamen, vormt het ζ.g. mesolurbische dopamine systeem 
een belangrijk onderdeel van de dopaminerge banen. Dit systeem ont­
springt in een groep cellen die m de middenhersenen mediaal van de 
substantia nigra Іідаеп, de ζ.g. A 10-groep, en zendt zenuwvezels naar 
enkele kernen van de linbische voorhersenen, voomainelijk de nucleus 
accmbens en het tuberculum olfactorium. In het verleden is bij de be­
studering van dopamine beïnvloedende psychofarmaca de aandacht bijna 
uitsluitend gericht geweest op het nigro-neostriatale systeem. Om tot 
een meer gedetailleerde kennis van de werking van deze stoffen te 
komen, is het noodzakelijk te weten wat de functie is van andere dopa-
minerge systemen en hoe farnaca deze beïnvloeden. 
De opzet van de m dit proefschrift beschreven experuienten was 
in dit verband het mesolirrbische dopamine systeem nader te onderzoeken. 
Met name de vraag of de bij dopaminerge stinulatie waargenomen verhoogde 
irotorische activiteit met dit systeem samenhangt vormde hierbij een be-
langrijk aspect. Ook was het de bedoeling te onderzoeken welke rol dit 
systeem speelt bij het tot stand komen van stereotypie, een gedrag dat 
gewoonlijk aan activering van het nigro-neostriatale systeem wordt toe-
^schreven. Deze vraagstukken werden benaderd door farnaca direct in de 
hersenen van de rat toe te dienen en het effect hiervan op het gedrag, 
т.п. de locarotorische activiteit, te bestuderen. Hierbij werd gebruik 
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gsnaakt- van stereotactisch ingebrachte cannules. De voomaairete injec-
tieplaats was de nucleus accuntens, crndat hier talrijke vezels van het 
mesolimbische dopanujie systeem eindigen. Hoewel de nucleus accunbens 
niet scherp gescheiden is van de aangrenzende nucleus caudatus en ook 
qua structuur zeer veel overeenkoist hiemee vertoont, blijken er toch 
duidelijke verschillen tussen deze twee kernen te bestaan in hun ver­
bindingen met andere delen van de hersenen. Dit zou er irogelijk op 
kinnen wijzen dat er oc* functionele verschillen tussen deze twee 
hersengebieden bestaan. Qn dit na te gaan werden in scmnige experi­
menten de effecten van injecties in de nucleus accunbens vergeleken 
met die van injecties in de nucleus caudatus. 
In Sectie I worden experunenten beschreven, waarin het effect van 
dopamme en andere stoffen op de notorische activiteit wordt nagegaan 
na bilaterale toediening hiervan in de nucleus ассшЬепз. Hierbij werd 
gevonden dat dopamine op deze wijze gegeven aan ratten, die waren \roor-
behandeld met nialamide - een stof die de afbraak van dopamine rant -
een sterke en langdurige verhoging van de notorische activiteit te zien 
gaf. Noradrenaline, een neurotransmitter die ook in de nucleus accun­
bens voorkomt, naar in veel lagere concentratie dan dopamine, bleek een 
soortgelijke, doch duidelijk minder intense motorische stimulering 
teweeg te brengen. Teneinde na te gaan of deze verhoogde activiteit 
mogelijk op meerdere wijzen tot stand kan komsn, werden ctopamine-ren»-
mende resp. noradrenaline-rarmande stoffen toegediend. Haloperidol, 
een stof die vrij specifiek de dopamine receptor blokkeert, bleek 
zowel het effect van dopamine als dat van noradrenalire sterk te re­
duceren. Daarentegen bleken phentolamine en propranolol, stoffen die 
hoofdzakelijk de noradrenaline receptor blokkeren, nodi het effect van 
noradrenaline nodi dat van accanine te rennen. Deze resultaten leicten 
tot de conclusie dat het effect, gezien na toediening van noradrenaline, 
indirect tot stand kont, namelijk door dopamtnezge act iva tie. Dit ken 
-4-
verder bevestigd worden door expermcnten net ratten, die geen niala-
midä als voorbehandeling hadden ontvangen. In deze dieren werd geen 
verhoogde activiteit waargenanen wanneer noradrenaline werd toegediend 
m de nucleus accmfaens. Evenmin werd een dergelijk effect verkregen 
na het geven van phenylephrine, isoprenaline en Clonidine, stoffen die 
een stinulerende werking hebben op noradrenaline receptoren. Dopanune 
bleek echter in deze dieren wel werk7aain, zi") het dat de waargenomen 
verhoogde motorische activiteit duidelijk veel körtet van duur was dan 
na voorbehandeling met nialamide. Dit effect van dopanune kon, evenals 
bi] de voorgaande experiiienten, geremd worden door haloper idol. Aan-
gezien de uit dopamine gevormde stofwisselingsprodukten 3-methoxy-
tyramine, DOPAC en HVA geen of naiwelijks effect hadden na directe 
toediening kan men stellen dat het dopamine zelf verantwoordelijk is 
voor het tot stand konen van deze stimüering van notorische activi-
teit. Verder werd gevonden dat d-anphetamine, een stof die, in bepaal-
de doseringen perifeer ingespoten, de motorische activiteit stutuleert, 
een soortgelijk effect te zien gaf na directe toediening in de nucleus 
acembens. Dit is een aanwijzing dat het mesoluibische dopamine systeem 
een belangrijke rol vervult in dit effect van d-anphetamine. Ook apo-
morfine, een stof met dopamine receptor stimulerende werking, veroor-
zaakte in een aantal gevallen een duidelijke stmulering van motorische 
activiteit. Een andere bevinding was dat toediening van bovengenoemde 
stoffen in het tuberculum olfactorium, een gebied waar ook vezels van 
het mesolinbische dopamme systeem eindigen, grotendeels dezelfde ef-
fecten te zien gaf als bij de nucleus aocunbens. Hierbij moet echter 
worden opepmerkt dat injecties in het tuberculum olfactoriun, vanwege 
zijn vorm en ligging, technisch gezien meer problanen opleveren dan die 
in de nucleus accuttoens. Het kan daaron niet net zekerheid worden uit-
gesloten dat de gevonden effecten moeten worden toegeschreven aan een 
verspreiding van de toegediende farmaca naar de nucleus acembens. 
-5-
Sectie II bevat onderzoeken die tot doel hadden cm te weten te 
kanen of er verschillen bestaan tussen het nesolurbische en het nigro-
neostriatale dopamine systeem net betrekking tot gedragseffecten, op-
gewekt door perifere toediening van fannaca met dopamine stimulerende 
eigenschappen. Er bestaan aanwijzingen dat bij de stuiuLering van 
motorische activiteit na het geven van lage doseringen anphetamine 
zowel dopamine als noradrenaline een rol spelen, terwijl bi] de 
stereotypie die gezien wordt na toedienen van anphetamine in hogere 
dosering en eck. na aparorfine voornamelijk dopamine betrokken zou zijn. 
Bij de vemciite experimenten werd gevonden dat de stimulatie van 
motorische activiteit na d-anphetamme duidelijk kon vKïrden gerend 
door het locaal aanbrengen van de dopamine receptor blokkerende stof 
haloperidol in de nucleus accurrbens. Toediening van dezelfde doses 
haloperidol in de nucleus caudatus had echter geen rennende invloed 
op dit effect. De noradrenaline receptor blokkerende stoffen phentol-
atmne en propranolol konden dit ançhetamine effect niet raimen, noch 
na toediening in de nucleus accunbens, noch na toediening in de nucleus 
caudatus. Deze resultaten wijzen duidelijk op verschillen tussen het 
mesolinfcische en het nigro-neostriatale dopamine systeem en bevestigen 
nognoals dat het mesolirrbische dopamine systeem een belangrijke rol 
speelt bij de door anphetamine geïnduceerde verhoogde motorische ac-
tiviteit. De door anphetamine en ook de door aponorfme usreorzaakte 
stereotypie bleek geremd te kinnen vrorden door injectie van haloperidol 
zowel in de nucleus acembens als in de nucleus caudatus. Dit wijst 
erop dat naast het nigro-neostriatale ook het mesolinbiscáie dopamine 
systeem van belang is bij het tot stand kernen van dit gedrag. 
In Sectie III worden experinenten beschreven, waarin het effect 
van ergot derivaten op dopamine systemen m het centrale zenuwstelsel 
van de rat werd onderzocht. Uit resultaten van studies bij ongewervelde 
dieren, o.a. de slak, is namelijk gebleken dat bepaalde ergot derivaten, 
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met name ergoTEtrine, zeer sterk wsrkzame en specifieke renners zijn 
van het effect van dopamine op zenuwcellen van deze dieren. Om deze 
reden leek het van belang na te gaan of een dergelijke dopamine rem-
mende werking ooV bi] de rat zou kunnen worden gevonden. Hierbi] werd 
waargenomen dat, in tegenstelling tot neurcleptica die bij de rat en 
andere zoogdieren een dopamine rennende invloed uitoefenen, ergometrine 
niet in staat bleek om de door aporrorfine opgewekte stereotypie te 
rennen, maar deze eerder versterkte. Vterder bleek dat bilaterale toe-
diening van ergonetrme in de nucleus accmbens resulteerde in een 
sterke en langdurige verhoging van de motorische activiteit. Ttoediening 
m de nucleus caudatus veroorzaakte slechts een geringe verhoging van 
de notorische activiteit. De verhoogde activiteit, opgewekt door in-
jectie in de nucleus acctmtens, was sterk gereduceerd wanneer ratten 
waren voorbehandeld met de neuroleptica haloperidol en pimozide. Na 
renning van de synthese van dopamine met behulp van a-nethyl-p-tyrosine 
bleek ergaietrine nog steeds in staat te zijn dit effect op te wekken. 
Deze resultaten doen venroeden dat ergometrine een stmulerende werking 
heeft op dopamine receptoren in de nucleus accmbens. Dit vermoeden 
wordt versterkt door het feit dat de door ergometrine opgewekte ver-
hoo^äe motorische activiteit geremd ken worden door halcperictol direct 
in de nucleus accmbens toe te dienen, zodat mogelijke effecten van 
deze stof op andere delen van de hersenen hierbij konden worden uitge-
sloten. Enigszins onverwacht echter bleken verschillende andere ergot 
derivaten, zoals o.a. ergooomine en bromocryptme, waarvan eveneens 
een dopamine stinulerende werking bij ratten is beschreven, met in 
staat eenzelfde notorische stimulatie te veroorzaken na injectie m de 
nucleus accmbens. De mogelijkheid bestaat echter dat hogere doseringen 
wel effect gehad zouden hebben. Vanvrege de slechte oplosbaarheid van 
deze stoffen kon dit met verder wordsi onderzocht. Een verdere be-
vinding was dat het effect van ergaietrine sterk werd gerend door № 1 , 
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een Imidazoline derivaat, waarvan dopamine stimulerende eigenschappen 
zijn beschreven op bepaalde cellen van de slakkehersenen als ook in 
de hersenen van de kat. Dit gegeven zou er op zijn beurt weer op kun­
nen wijzen dat ergotnetrine een dopamine rennend effect heeft evenals 
bij de slak. № 1 zelf echter gaf geen verhoogde notorische activiteit 
te zien na injectie in de nucleus accmbens. Omdat onlangs uit studies 
bij slakken is gebleken dat er twee verschillende typen dopamine recep­
toren bestaan en DPI slechts op een type werkzaam is, terwijl ergo-
netrine op beide inwerkt, is de rrogclijkheid niet uitgesloten dat ook 
in de hersenen van de rat verschillende typen dopamine receptoren be­
staan. Of dit inderdaad het geval is en hoe ergometrine hierop inwerkt 
zal uit verder onderzoek moeten blijken. 
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